8 EVOLUTION OF TREATMENT-EMERGENT RESISTANT VARIANTS IN TELAPREVIR PHASE 3 CLINICAL TRIALS (Englisch)
- Neue Suche nach: Sullivan, J. C.
- Neue Suche nach: De Meyer, S.
- Neue Suche nach: Bartels, D. J.
- Neue Suche nach: Dierynck, I.
- Neue Suche nach: Zhang, E.
- Neue Suche nach: Spanks, J.
- Neue Suche nach: Tigges, A.
- Neue Suche nach: Adda, N.
- Neue Suche nach: Martin, E. C.
- Neue Suche nach: Beumont, M.
- Neue Suche nach: Sullivan, J. C.
- Neue Suche nach: De Meyer, S.
- Neue Suche nach: Bartels, D. J.
- Neue Suche nach: Dierynck, I.
- Neue Suche nach: Zhang, E.
- Neue Suche nach: Spanks, J.
- Neue Suche nach: Tigges, A.
- Neue Suche nach: Adda, N.
- Neue Suche nach: Martin, E. C.
- Neue Suche nach: Beumont, M.
In:
JOURNAL OF HEPATOLOGY
;
54
;
S4
;
2011
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:8 EVOLUTION OF TREATMENT-EMERGENT RESISTANT VARIANTS IN TELAPREVIR PHASE 3 CLINICAL TRIALS
-
Beteiligte:Sullivan, J. C. ( Autor:in ) / De Meyer, S. ( Autor:in ) / Bartels, D. J. ( Autor:in ) / Dierynck, I. ( Autor:in ) / Zhang, E. ( Autor:in ) / Spanks, J. ( Autor:in ) / Tigges, A. ( Autor:in ) / Adda, N. ( Autor:in ) / Martin, E. C. ( Autor:in ) / Beumont, M. ( Autor:in )
-
Erschienen in:JOURNAL OF HEPATOLOGY ; 54 ; S4
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam.
-
Erscheinungsdatum:01.01.2011
-
Format / Umfang:S4
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.3623
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.3623 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 54
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
FocusShouval, D. et al. | 2011
- 3
-
First year and beyondSamuel, D. et al. | 2011
- 4
-
From volcano clouds to iLivers: EASL growing in times of changeWedemeyer, H. et al. | 2011
- 6
-
Study of adherence comes to the treatment of chronic hepatitis BLee, M. / Keeffe, E. B. et al. | 2011
- 9
-
Hepatitis E: Water, water everywhere - Now a Global DiseaseAcharya, S. K. / Panda, S. K. et al. | 2011
- 12
-
Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis BChotiyaputta, W. / Peterson, C. / Ditah, F. A. / Goodwin, D. / Lok, A. S. et al. | 2011
- 19
-
Evolution of hepatitis B genotype C viral quasi-species during hepatitis B e antigen seroconversionWu, S. / Imazeki, F. / Kurbanov, F. / Fukai, K. / Arai, M. / Kanda, T. / Yonemitsu, Y. / Tanaka, Y. / Mizokami, M. / Yokosuka, O. et al. | 2011
- 26
-
Hepatitis B virus X protein stimulates IL-6 expression in hepatocytes via a MyD88-dependent pathwayXiang, W. Q. / Feng, W. F. / Ke, W. / Sun, Z. / Chen, Z. / Liu, W. et al. | 2011
- 34
-
Hepatitis E in Italy: A long-term prospective studyRomano, L. / Paladini, S. / Tagliacarne, C. / Canuti, M. / Bianchi, S. / Zanetti, A. R. et al. | 2011
- 41
-
Insulin resistance predicts re-treatment failure in an efficacy study of peginterferon-a-2a and ribavirin in HIV/HCV co-infected patientsVachon, M. L. / Factor, S. H. / Branch, A. D. / Fiel, M. I. / Rodriguez-Torres, M. / Brau, N. / Sterling, R. K. / Slim, J. / Talal, A. H. / Dieterich, D. T. et al. | 2011
- 48
-
Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitorsSyder, A. J. / Lee, H. / Zeisel, M. B. / Grove, J. / Soulier, E. / Macdonald, J. / Chow, S. / Chang, J. / Baumert, T. F. / McKeating, J. A. et al. | 2011
- 56
-
Bleeding in patients with Budd-Chiari syndromeRautou, P. E. / Douarin, L. / Denninger, M. H. / Escolano, S. / Lebrec, D. / Moreau, R. / Vidaud, M. / Itzykson, R. / Moucari, R. / Bezeaud, A. et al. | 2011
- 64
-
Reliability of transient elastography for the detection of fibrosis in Non-Alcoholic Fatty Liver Disease and chronic viral hepatitisGaia, S. / Carenzi, S. / Barilli, A. L. / Bugianesi, E. / Smedile, A. / Brunello, F. / Marzano, A. / Rizzetto, M. et al. | 2011
- 72
-
Sub-clinical hepatic encephalopathy in cirrhotic patients is not aggravated by sedation with propofol compared to midazolam: A randomized controlled studyKhamaysi, I. / William, N. / Olga, A. / Alex, I. / Vladimir, M. / Kamal, D. / Nimer, A. et al. | 2011
- 78
-
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosisHan, G. / Qi, X. / He, C. / Yin, Z. / Wang, J. / Xia, J. / Yang, Z. / Bai, M. / Meng, X. / Niu, J. et al. | 2011
- 89
-
Osteopontin expression predicts overall survival after liver transplantation for hepatocellular carcinoma in patients beyond the Milan criteriaSieghart, W. / Wang, X. / Schmid, K. / Pinter, M. / Konig, F. / Bodingbauer, M. / Wrba, F. / Rasoul-Rockenschaub, S. / Peck-Radosavljevic, M. et al. | 2011
- 98
-
Directed differentiation of murine-induced pluripotent stem cells to functional hepatocyte-like cellsSancho-Bru, P. / Roelandt, P. / Narain, N. / Pauwelyn, K. / Notelaers, T. / Shimizu, T. / Ott, M. / Verfaillie, C. et al. | 2011
- 108
-
Development and validation of a new prognostic score of death for patients with hepatocellular carcinoma in palliative settingTournoux-Facon, C. / Paoletti, X. / Barbare, J. C. / Bouche, O. / Rougier, P. / Dahan, L. / Lombard-Bohas, C. / Faroux, R. / Raoul, J. L. / Bedenne, L. et al. | 2011
- 115
-
AFP-specific immunotherapy impairs growth of autochthonous hepatocellular carcinoma in miceCany, J. / Barteau, B. / Tran, L. / Gauttier, V. / Archambeaud, I. / Couty, J. P. / Turlin, B. / Pitard, B. / Vassaux, G. / Ferry, N. et al. | 2011
- 122
-
Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cellsPark, J. R. / Kim, R. J. / Lee, Y. K. / Kim, S. R. / Roh, K. J. / Oh, S. H. / Kong, G. / Kang, K. S. / Nam, J. S. et al. | 2011
- 132
-
Distinct roles for non-muscle myosin II isoforms in mouse hepatic stellate cellsLiu, Z. / Rossen, E. V. / Timmermans, J. P. / Geerts, A. / van Grunsven, L. A. / Reynaert, H. et al. | 2011
- 142
-
Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis CGarcia-Monzon, C. / Lo Iacono, O. / Mayoral, R. / Gonzalez-Rodriguez, A. / Miquilena-Colina, M. E. / Lozano-Rodriguez, T. / Garcia-Pozo, L. / Vargas-Castrillon, J. / Casado, M. / Bosca, L. et al. | 2011
- 153
-
Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesitySimonen, P. / Kotronen, A. / Hallikainen, M. / Sevastianova, K. / Makkonen, J. / Hakkarainen, A. / Lundbom, N. / Miettinen, T. A. / Gylling, H. / Yki-Jarvinen, H. et al. | 2011
- 160
-
Comparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver diseaseRuffillo, G. / Fassio, E. / Alvarez, E. / Landeira, G. / Longo, C. / Dominguez, N. / Gualano, G. et al. | 2011
- 164
-
Activation of p53 enhances apoptosis and insulin resistance in a rat model of alcoholic liver diseaseDerdak, Z. / Lang, C. H. / Villegas, K. A. / Tong, M. / Mark, N. M. / de la Monte, S. M. / Wands, J. R. et al. | 2011
- 173
-
Hepcidin in human iron disorders: Therapeutic implicationsPietrangelo, A. et al. | 2011
- 182
-
Inhibition of mammalian target of rapamycin: Two goals with one shot?Soll, C. / Clavien, P. A. et al. | 2011
- 184
-
Evolving strategies in the diagnosis of hepatocellular carcinomaLencioni, R. et al. | 2011
- 187
-
Microarchitecture of the liver: A Jigsaw puzzleRojkind, M. / Philips, G. / Diehl, A. M. et al. | 2011
- 191
-
The GAPs between hepatocellular carcinoma and RASGuachalla, L. M. / Rudolph, K. L. et al. | 2011
- 193
-
Recognizing autoimmune hepatitis: Scores help, but no moreLohse, A. W. et al. | 2011
- 195
-
Profiles of HBV DNA in a large population of Chinese patients with chronic hepatitis B: Implications for antiviral therapyFung, J. / Seto, W. K. / Lai, C. L. / Yuen, J. / Wong, D. K. / Yuen, M. F. et al. | 2011
- 201
-
Characterization of CD8+ T-cell response in acute and resolved hepatitis A virus infectionSchulte, I. / Hitziger, T. / Giugliano, S. / Timm, J. / Gold, H. / Heinemann, F. M. / Khudyakov, Y. / Strasser, M. / Konig, C. / Castermans, E. et al. | 2011
- 209
-
Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis BTjwa, E. T. / van Oord, G. W. / Hegmans, J. P. / Janssen, H. L. / Woltman, A. M. et al. | 2011
- 219
-
The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies - A multicenter prospective trialHuang, J. F. / Yu, M. L. / Huang, C. F. / Chiu, C. F. / Dai, C. Y. / Huang, C. I. / Yeh, M. L. / Yang, J. F. / Hsieh, M. Y. / Hou, N. J. et al. | 2011
- 227
-
FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC3 programPoynard, T. / Munteanu, M. / Colombo, M. / Bruix, J. / Schiff, E. / Terg, R. / Flamm, S. / Moreno-Otero, R. / Carrilho, F. / Schmidt, W. et al. | 2011
- 236
-
Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis BWong, V. W. / Wong, G. L. / Yiu, K. K. / Chim, A. M. / Chu, S. H. / Chan, H. Y. / Sung, J. J. / Chan, H. L. et al. | 2011
- 243
-
Assessment of adrenocortical reserve in stable patients with cirrhosisFede, G. / Spadaro, L. / Tomaselli, T. / Privitera, G. / Piro, S. / Rabuazzo, A. M. / Sigalas, A. / Xirouchakis, E. / O'Beirne, J. / Garcovich, M. et al. | 2011
- 251
-
Locomotor impairment and cerebrocortical oxidative stress in portal vein ligated rats in vivoBruck, J. / Gorg, B. / Bidmon, H. J. / Zemtsova, I. / Qvartskhava, N. / Keitel, V. / Kircheis, G. / Haussinger, D. et al. | 2011
- 258
-
Heme oxygenase regulates renal arterial resistance and sodium excretion in cirrhotic ratsDi Pascoli, M. / Zampieri, F. / Quarta, S. / Sacerdoti, D. / Merkel, C. / Gatta, A. / Bolognesi, M. et al. | 2011
- 265
-
Acute endotoxemia following transjugular intrahepatic stent-shunt insertion is associated with systemic and cerebral vasodilatation with increased whole body nitric oxide production in critically ill cirrhotic patientsJalan, R. / Olde Damink, S. W. / ter Steege, J. C. / Redhead, D. N. / Lee, A. / Hayes, P. C. / Deutz, N. E. et al. | 2011
- 272
-
The Na-K-Cl cotransporter in the brain edema of acute liver failureJayakumar, A. R. / Valdes, V. / Norenberg, M. D. et al. | 2011
- 279
-
Scaffolds containing growth factors and extracellular matrix induce hepatocyte proliferation and cell migration in normal and regenerating rat liverHammond, J. S. / Gilbert, T. W. / Howard, D. / Zaitoun, A. / Michalopoulos, G. / Shakesheff, K. M. / Beckingham, I. J. / Badylak, S. F. et al. | 2011
- 288
-
Pharmacological inhibition of Frizzled-7 displays anti-tumor properties in hepatocellular carcinomaNambotin, S. B. / Lefrancois, L. / Sainsily, X. / Berthillon, P. / Kim, M. / Wands, J. R. / Chevallier, M. / Jalinot, P. / Scoazec, J. Y. / Trepo, C. et al. | 2011
- 300
-
Pre-operative liver biopsy in cirrhotic patients with early hepatocellular carcinoma represents a safe and accurate diagnostic tool for tumour grading assessmentColecchia, A. / Scaioli, E. / Montrone, L. / Vestito, A. / Di Biase, A. R. / Pieri, M. / D'Errico-Grigioni, A. / Bacchi-Reggiani, M. L. / Ravaioli, M. / Grazi, G. L. et al. | 2011
- 306
-
Trends in the incidence and management of biliary tract cancer: A French population-based studyLepage, C. / Cottet, V. / Chauvenet, M. / Phelip, J. M. / Bedenne, L. / Faivre, J. / Bouvier, A. M. et al. | 2011
- 311
-
Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancerCalvisi, D. F. / Ladu, S. / Conner, E. A. / Seo, D. / Hsieh, J. T. / Factor, V. M. / Thorgeirsson, S. S. et al. | 2011
- 320
-
Efficiency of oxidative phosphorylation in liver mitochondria is decreased in a rat model of peritoneal carcinosisDumas, J. F. / Goupille, C. / Julienne, C. M. / Pinault, M. / Chevalier, S. / Bougnoux, P. / Servais, S. / Couet, C. et al. | 2011
- 328
-
Human carbonyl reductase 1 upregulated by hypoxia renders resistance to apoptosis in hepatocellular carcinoma cellsTak, E. / Lee, S. / Lee, J. / Rashid, M. A. / Kim, Y. W. / Park, J. H. / Park, W. S. / Shokat, K. M. / Ha, J. / Kim, S. S. et al. | 2011
- 340
-
Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patientsQiu, D. / Wang, Q. / Wang, H. / Xie, Q. / Zang, G. / Jiang, H. / Tu, C. / Guo, J. / Zhang, S. / Wang, J. et al. | 2011
- 348
-
Effects of a high-fat diet on energy metabolism and ROS production in rat liverVial, G. / Dubouchaud, H. / Couturier, K. / Cottet-Rousselle, C. / Taleux, N. / Athias, A. / Galinier, A. / Casteilla, L. / Leverve, X. M. et al. | 2011
- 357
-
Liver antigen-presenting cellsCrispe, I. N. et al. | 2011
- 366
-
Hedgehog signaling in the liverOmenetti, A. / Choi, S. / Michelotti, G. / Diehl, A. M. et al. | 2011
- 374
-
Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issueBoberg, K. M. / Chapman, R. W. / Hirschfield, G. M. / Lohse, A. W. / Manns, M. P. / Schrumpf, E. et al. | 2011
- 386
-
A reengineered liver for transplantationMoniaux, N. / Faivre, J. et al. | 2011
- 388
-
Insulin resistance and oxidative stress: Two therapeutic targets in non-alcoholic steatohepatitisVoican, C. S. / Perlemuter, G. et al. | 2011
- 392
-
Pathogenesis of cholestatic hepatitis CMcCaughan, G. W. / Bowen, D. G. et al. | 2011
- 395
-
The importance of HBV genotype in HBeAg-positive chronic hepatitis B patients in whom sustained response is pursuedBuster, E. H. / Janssen, H. L. et al. | 2011
- 396
-
mTOR inhibitors and sorafenib for recurrent heptocellular carcinoma after orthotopic liver transplantationWaidmann, O. / Hofmann, W. P. / Zeuzem, S. / Trojan, J. et al. | 2011
- 396
-
HBV genotype must be included in treatment algorithmMondelli, M. U. / Raimondi, S. / Bruno, S. / Maisonneuve, P. et al. | 2011
- 398
-
Magnetic resonance spectroscopy of bile in the detection of cholangiocarcinomaIjare, O. B. / Bezabeh, T. / Albiin, N. / Smith, I. C. et al. | 2011
- 399
-
A new NMR metabolomics-based diagnosis for hepatobiliary tract cancerWen, H. / Yoo, S. S. / Lee, D. H. / Park, S. et al. | 2011
- 401
-
The quest for equity in liver transplantation: Another lesson learned from womenDurand, F. et al. | 2011
- 403
-
Long distance calling for liver regeneration: Identification of neuroendocrine signalling pathways activated after partial hepatectomyAvila, M. A. et al. | 2011
- 406
-
Regulation of the expression of the hepatocellular sulfate-oxalate exchanger SAT-1 (SLC26A1) by glyoxylate: A metabolic link between liver and kidney?Stieger, B. et al. | 2011
- 408
-
Predictive value of the IL28B polymorphism on the effect of interferon therapy in chronic hepatitis C patients with genotypes 2a and 2bKawaoka, T. / Hayes, C. N. / Ohishi, W. / Ochi, H. / Maekawa, T. / Abe, H. / Tsuge, M. / Mitsui, F. / Hiraga, N. / Imamura, M. et al. | 2011
- 415
-
Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patientsSarrazin, C. / Susser, S. / Doehring, A. / Lange, C. M. / Muller, T. / Schlecker, C. / Herrmann, E. / Lotsch, J. / Berg, T. et al. | 2011
- 422
-
Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infectionRiezu-Boj, J. I. / Larrea, E. / Aldabe, R. / Guembe, L. / Casares, N. / Galeano, E. / Echeverria, I. / Sarobe, P. / Herrero, I. / Sangro, B. et al. | 2011
- 432
-
Pathogenesis of lipid metabolism disorder in hepatitis C: Polyunsaturated fatty acids counteract lipid alterations induced by the core proteinMiyoshi, H. / Moriya, K. / Tsutsumi, T. / Shinzawa, S. / Fujie, H. / Shintani, Y. / Fujinaga, H. / Goto, K. / Todoroki, T. / Suzuki, T. et al. | 2011
- 439
-
Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factorsKurosaki, M. / Tanaka, Y. / Nishida, N. / Sakamoto, N. / Enomoto, N. / Honda, M. / Sugiyama, M. / Matsuura, K. / Sugauchi, F. / Asahina, Y. et al. | 2011
- 449
-
Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavirReijnders, J. G. / Rijckborst, V. / Sonneveld, M. J. / Scherbeijn, S. M. / Boucher, C. A. / Hansen, B. E. / Janssen, H. L. et al. | 2011
- 455
-
Obliterative portal venopathy: Portal hypertension is not always present at diagnosisCazals-Hatem, D. / Hillaire, S. / Rudler, M. / Plessier, A. / Paradis, V. / Condat, B. / Francoz, C. / Denninger, M. H. / Durand, F. / Bedossa, P. et al. | 2011
- 462
-
Gender, renal function, and outcomes on the liver transplant waiting list: Assessment of revised MELD including estimated glomerular filtration rateMyers, R. P. / Shaheen, A. A. / Aspinall, A. I. / Quinn, R. R. / Burak, K. W. et al. | 2011
- 471
-
The protective role of hydrogen-rich saline in experimental liver injury in miceSun, H. / Chen, L. / Zhou, W. / Hu, L. / Li, L. / Tu, Q. / Chang, Y. / Liu, Q. / Sun, X. / Wu, M. et al. | 2011
- 481
-
Immediate neuroendocrine signaling after partial hepatectomy through acute portal hyperpressure and cholestasisDoignon, I. / Julien, B. / Serriere-Lanneau, V. / Garcin, I. / Alonso, G. / Nicou, A. / Monnet, F. / Gigou, M. / Humbert, L. / Rainteau, D. et al. | 2011
- 489
-
The role of nucleoside and nucleotide analogues in nodular regenerative hyperplasia in HIV-infected patients: A case control studyCotte, L. / Benet, T. / Billioud, C. / Miailhes, P. / Scoazec, J. Y. / Ferry, T. / Brochier, C. / Boibieux, A. / Vanhems, P. / Chevallier, M. et al. | 2011
- 497
-
Intratumoral neutrophils: A poor prognostic factor for hepatocellular carcinoma following resectionLi, Y. W. / Qiu, S. J. / Fan, J. / Zhou, J. / Gao, Q. / Xiao, Y. S. / Xu, Y. F. et al. | 2011
- 506
-
Pegylated interferon alpha targets Wnt signaling by inducing nuclear export of b-cateninThompson, M. D. / Dar, M. J. / Monga, S. P. et al. | 2011
- 513
-
Glyoxylate is a substrate of the sulfate-oxalate exchanger, sat-1, and increases its expression in HepG2 cellsSchnedler, N. / Burckhardt, G. / Burckhardt, B. C. et al. | 2011
- 521
-
TGF-b1 mediated activation of Rho kinase induces TGF-b2 and endothelin-1 expression in human hepatic stellate cellsShimada, H. / Staten, N. R. / Rajagopalan, L. E. et al. | 2011
- 529
-
Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomasMutel, E. / Abdul-Wahed, A. / Ramamonjisoa, N. / Stefanutti, A. / Houberdon, I. / Cavassila, S. / Pilleul, F. / Beuf, O. / Gautier-Stein, A. / Penhoat, A. et al. | 2011
- 538
-
G80S-linked ferroportin disease: Classical ferroportin disease in an Asian family and reclassification of the mutant as iron transport defectiveMcDonald, C. J. / Wallace, D. F. / Ostini, L. / Bell, S. J. / Demediuk, B. / Subramaniam, V. N. et al. | 2011
- 545
-
Liver and pancreatic fat content and metabolism in healthy monozygotic twins with discordant physical activityHannukainen, J. C. / Borra, R. / Linderborg, K. / Kallio, H. / Kiss, J. / Lepomaki, V. / Kalliokoski, K. K. / Kujala, U. M. / Kaprio, J. / Heinonen, O. J. et al. | 2011
- 553
-
Management of hepatocellular adenoma during pregnancyNoels, J. E. / van Aalten, S. M. / van der Windt, D. J. / Kok, N. F. / de Man, R. A. / Terkivatan, T. / IJzermans, J. N. et al. | 2011
- 559
-
Symptomatic-enlarging hepatic hemangiomas are effectively treated by percutaneous ultrasonography-guided radiofrequency ablationPark, S. Y. / Tak, W. Y. / Jung, M. K. / Jeon, S. W. / Cho, C. M. / Kweon, Y. O. / Kim, K. C. et al. | 2011
- 566
-
Hepatitis C virus entry into hepatocytes: Molecular mechanisms and targets for antiviral therapiesZeisel, M. B. / Fofana, I. / Fafi-Kremer, S. / Baumert, T. F. et al. | 2011
- 577
-
Combination of gemcitabine and cisplatin for biliary tract cancer: A platform to build onRazumilava, N. / Gores, G. J. et al. | 2011
- 579
-
Abnormal nitrosothiol metabolism in hepatocellular carcinomaMartin, J. / Dufour, J. F. et al. | 2011
- 581
-
Platelet-derived chemokines: New targets to treat liver fibrosisMorales-Ibanez, O. / Bataller, R. et al. | 2011
- 584
-
Rolls Royce for everybody? Diagnosing liver disease by mini-laparoscopyLohse, A. W. et al. | 2011
- 586
-
First-line assessment of patients with chronic liver disease with non-invasive techniques and without recourse to liver biopsyPoynard, T. et al. | 2011
- 588
-
Changes in the 24-h plasma cortisol rhythm in patients with cirrhosisMontagnese, S. / Middleton, B. / Mani, A. R. / Skene, D. J. / Morgan, M. Y. et al. | 2011
- 590
-
Adrenal insufficiency: Diagnosis in patients with liver cirrhosis is difficultGalbois, A. / Thabut, D. et al. | 2011
- 591
-
Silibinin monotherapy prevents graft infection after orthotopic liver transplantation in a patient with chronic hepatitis CBeinhardt, S. / Rasoul-Rockenschaub, S. / Scherzer, T. M. / Ferenci, P. et al. | 2011
- 592
-
Silibinin in hepatitis C related liver transplantationBerg, T. / Biermer, M. / Neumann, U. et al. | 2011
- 593
-
Anemia - The overlooked factor in bleeding related to liver diseaseThachil, J. et al. | 2011
- 594
-
Anemia as a potential contributor to bleeding in patients with liver disease - Neglected but not forgottenLisman, T. / Caldwell, S. H. / Porte, R. J. et al. | 2011
- 599
-
Herbal medicine hepatotoxicity: A new step with development of specific biomarkersLarrey, D. / Faure, S. et al. | 2011
- 602
-
Methylation profile as a new tool for classification of hepatocellular carcinomaPerret, C. et al. | 2011
- 604
-
Indications and limitations for aged patients with chronic hepatitis C in pegylated interferon alfa-2b plus ribavirin combination therapyOze, T. / Hiramatsu, N. / Yakushijin, T. / Mochizuki, K. / Oshita, M. / Hagiwara, H. / Mita, E. / Ito, T. / Fukui, H. / Inui, Y. et al. | 2011
- 612
-
HIV infection increases HCV-induced hepatocyte apoptosisJang, J. Y. / Shao, R. X. / Lin, W. / Weinberg, E. / Chung, W. J. / Tsai, W. L. / Zhao, H. / Goto, K. / Zhang, L. / Mendez-Navarro, J. et al. | 2011
- 621
-
Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or CFraquelli, M. / Rigamonti, C. / Casazza, G. / Donato, M. F. / Ronchi, G. / Conte, D. / Rumi, M. / Lampertico, P. / Colombo, M. et al. | 2011
- 629
-
A single nucleotide polymorphism in activated cdc42 associated tyrosine kinase 1 influences the interferon therapy in hepatitis C patientsFujimoto, Y. / Ochi, H. / Maekawa, T. / Abe, H. / Hayes, C. N. / Kumada, H. / Nakamura, Y. / Chayama, K. et al. | 2011
- 640
-
Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosisShawcross, D. L. / Sharifi, Y. / Canavan, J. B. / Yeoman, A. D. / Abeles, R. D. / Taylor, N. J. / Auzinger, G. / Bernal, W. / Wendon, J. A. et al. | 2011
- 650
-
Elastography for the diagnosis of severity of fibrosis in chronic liver disease: A meta-analysis of diagnostic accuracyTsochatzis, E. A. / Gurusamy, K. S. / Ntaoula, S. / Cholongitas, E. / Davidson, B. R. / Burroughs, A. K. et al. | 2011
- 660
-
Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic ratsGarcia-Caldero, H. / Rodriguez-Vilarrupla, A. / Gracia-Sancho, J. / Divi, M. / Lavina, B. / Bosch, J. / Garcia-Pagan, J. C. et al. | 2011
- 666
-
Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetumLin, G. / Wang, J. Y. / Li, N. / Li, M. / Gao, H. / Ji, Y. / Zhang, F. / Wang, H. / Zhou, Y. / Ye, Y. et al. | 2011
- 674
-
The synthetic bile acid-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide suppresses TNFa-induced liver injuryPathil, A. / Warth, A. / Chamulitrat, W. / Stremmel, W. et al. | 2011
- 685
-
Synergism between p53 and Mcl-1 in protecting from hepatic injury, fibrosis and cancerWeng, S. Y. / Yang, C. Y. / Li, C. C. / Sun, T. P. / Tung, S. Y. / Yen, J. J. / Tsai, T. F. / Chen, C. M. / Chen, S. H. / Hsiao, M. et al. | 2011
- 695
-
Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: Radiologic-pathologic correlationRiaz, A. / Memon, K. / Miller, F. H. / Nikolaidis, P. / Kulik, L. M. / Lewandowski, R. J. / Ryu, R. K. / Sato, K. T. / Gates, V. L. / Mulcahy, M. F. et al. | 2011
- 705
-
Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intakeLambert, M. P. / Paliwal, A. / Vaissiere, T. / Chemin, I. / Zoulim, F. / Tommasino, M. / Hainaut, P. / Sylla, B. / Scoazec, J. Y. / Tost, J. et al. | 2011
- 716
-
IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: Role in the course of chronic viral hepatitis and the development of HCCFabris, C. / Falleti, E. / Cussigh, A. / Bitetto, D. / Fontanini, E. / Bignulin, S. / Cmet, S. / Fornasiere, E. / Fumolo, E. / Fangazio, S. et al. | 2011
- 723
-
Optimization of imaging diagnosis of 1-2cm hepatocellular carcinoma: An analysis of diagnostic performance and resource utilizationKhalili, K. / Kim, T. K. / Jang, H. J. / Haider, M. A. / Khan, L. / Guindi, M. / Sherman, M. et al. | 2011
- 729
-
ATF4 and the integrated stress response are induced by ethanol and cytochrome P450 2E1 in human hepatocytesMagne, L. / Blanc, E. / Legrand, B. / Lucas, D. / Barouki, R. / Rouach, H. / Garlatti, M. et al. | 2011
- 738
-
Transporters involved in the hepatic uptake of 99mTc-mebrofenin and indocyanine greende Graaf, W. / Hausler, S. / Heger, M. / van Ginhoven, T. M. / van Cappellen, G. / Bennink, R. J. / Kullak-Ublick, G. A. / Hesselmann, R. / van Gulik, T. M. / Stieger, B. et al. | 2011
- 746
-
NK cells suppress experimental cholestatic liver injury by an interleukin-6-mediated, Kupffer cell-dependent mechanismCheng, C. W. / Duwaerts, C. C. / Rooijen, N. v. / Wintermeyer, P. / Mott, S. / Gregory, S. H. et al. | 2011
- 753
-
Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver diseaseZein, C. O. / Unalp, A. / Colvin, R. / Liu, Y. C. / McCullough, A. J. et al. | 2011
- 760
-
Incidence and mortality of alcoholic hepatitis in Denmark 1999-2008: A nationwide population based cohort studySandahl, T. D. / Jepsen, P. / Thomsen, K. L. / Vilstrup, H. et al. | 2011
- 765
-
Glycogen synthase kinase-3 (GSK-3) inhibition attenuates hepatocyte lipoapoptosisIbrahim, S. H. / Akazawa, Y. / Cazanave, S. C. / Bronk, S. F. / Elmi, N. A. / Werneburg, N. W. / Billadeau, D. D. / Gores, G. J. et al. | 2011
- 773
-
Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liverBegriche, K. / Massart, J. / Robin, M. A. / Borgne-Sanchez, A. / Fromenty, B. et al. | 2011
- 795
-
Endoplasmic reticulum stress in liver diseaseMalhi, H. / Kaufman, R. J. et al. | 2011
- 810
-
The heart in liver transplantationRipoll, C. / Yotti, R. / Bermejo, J. / Banares, R. et al. | 2011
- 823
-
Power play: Scoring our goals for liver cancer with better GWAS study designBudhu, A. / Wang, X. W. et al. | 2011
- 825
-
Liver transplantation as a model to better understand the cell entry of hepatitis C virusFeray, C. et al. | 2011
- 827
-
Regulation of hepatic metabolism by AMPKForetz, M. / Viollet, B. et al. | 2011
- 830
-
Potential of immunotherapy for hepatocellular carcinomaBreous, E. / Thimme, R. et al. | 2011
- 835
-
Is HCV RNA analysis at day 7 cost-effective in deciding the duration of therapy in chronic HCV genotype 2/3 infection?Lagging, M. / Alsio, a. / Hellstrand, K. / Norkrans, G. et al. | 2011
- 836
-
Viral kinetics for individualized treatment durationsSarrazin, C. et al. | 2011
- 837
-
Reactivation of autoimmune hepatitis during budesonide monotherapy, and response to standard treatmentLohse, A. W. / Gil, H. et al. | 2011
- 844
-
Insights into the role of interferon lambda in hepatitis C virus infectionBarth, H. et al. | 2011
- 848
-
Evaluation of combination therapy against hepatitis C virus infection in human liver chimeric micede Jong, Y. P. / Rice, C. M. / Ploss, A. et al. | 2011
- 851
-
Adipose-tissue derived hepatic stem cells for gene therapy: Fat goes to liver's rescue?Ferry, N. et al. | 2011
- 853
-
The inflammatory microenvironment of HCC - The plot becomes complexSchrader, J. / Iredale, J. P. et al. | 2011
- 856
-
UDCA for NASH: End of the story?Haedrich, M. / Dufour, J. F. et al. | 2011
- 859
-
Interferon-lambda serum levels in hepatitis CLanghans, B. / Kupfer, B. / Braunschweiger, I. / Arndt, S. / Schulte, W. / Nischalke, H. D. / Nattermann, J. / Oldenburg, J. / Sauerbruch, T. / Spengler, U. et al. | 2011
- 866
-
Early virologic response and IL28B polymorphisms in patients with chronic hepatitis C genotype 3 treated with peginterferon alfa-2a and ribavirinScherzer, T. M. / Hofer, H. / Staettermayer, A. F. / Rutter, K. / Beinhardt, S. / Steindl-Munda, P. / Kerschner, H. / Kessler, H. H. / Ferenci, P. et al. | 2011
- 872
-
Elimination of hepatitis C virus by short term NS3-4A and NS5B inhibitor combination therapy in human hepatocyte chimeric miceOhara, E. / Hiraga, N. / Imamura, M. / Iwao, E. / Kamiya, N. / Yamada, I. / Kono, T. / Onishi, M. / Hirata, D. / Mitsui, F. et al. | 2011
- 879
-
Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006Walter, S. R. / Thein, H. H. / Amin, J. / Gidding, H. F. / Ward, K. / Law, M. G. / George, J. / Dore, G. J. et al. | 2011
- 887
-
Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapyLange, C. M. / Bojunga, J. / Ramos-Lopez, E. / von Wagner, M. / Hassler, A. / Vermehren, J. / Herrmann, E. / Badenhoop, K. / Zeuzem, S. / Sarrazin, C. et al. | 2011
- 894
-
Platelet production and destruction in liver cirrhosisPradella, P. / Bonetto, S. / Turchetto, S. / Uxa, L. / Comar, C. / Zorat, F. / De Angelis, V. / Pozzato, G. et al. | 2011
- 901
-
Serum bilirubin and platelet count: A simple predictive model for survival in patients with refractory ascites treated by TIPSBureau, C. / Metivier, S. / D'Amico, M. / Peron, J. M. / Otal, P. / Pagan, J. C. / Chabbert, V. / Chagneau-Derrode, C. / Procopet, B. / Rousseau, H. et al. | 2011
- 908
-
Proteomic analysis reveals that apolipoprotein A1 levels are decreased in patients with Budd-Chiari syndromeTalens, S. / Hoekstra, J. / Dirkx, S. P. / Murad, S. D. / Trebicka, J. / Elias, E. / Primignani, M. / Garcia-Pagan, J. C. / Valla, D. C. / Janssen, H. L. et al. | 2011
- 915
-
Sarcopenia associated with portosystemic shunting is reversed by follistatinDasarathy, S. / McCullough, A. J. / Muc, S. / Schneyer, A. / Bennett, C. D. / Dodig, M. / Kalhan, S. C. et al. | 2011
- 922
-
Early hepatocyte DNA synthetic response posthepatectomy is modulated by IL-6 trans-signaling and PI3K/AKT activationNechemia-Arbely, Y. / Shriki, A. / Denz, U. / Drucker, C. / Scheller, J. / Raub, J. / Pappo, O. / Rose-John, S. / Galun, E. / Axelrod, J. H. et al. | 2011
- 930
-
Adipose tissue-derived mesenchymal stem cell-based liver gene deliveryLi, H. / Zhang, B. / Lu, Y. / Jorgensen, M. / Petersen, B. / Song, S. et al. | 2011
- 939
-
Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesisUm, T. H. / Kim, H. / Oh, B. K. / Kim, M. S. / Kim, K. S. / Jung, G. / Park, Y. N. et al. | 2011
- 948
-
Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinomaKuang, D. M. / Zhao, Q. / Wu, Y. / Peng, C. / Wang, J. / Xu, Z. / Yin, X. Y. / Zheng, L. et al. | 2011
- 956
-
Hepatitis C virus and alcohol: Same mitotic targets but different signaling pathwaysAlisi, A. / Ghidinelli, M. / Zerbini, A. / Missale, G. / Balsano, C. et al. | 2011
- 964
-
Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cellsNovo, E. / Busletta, C. / Bonzo, L. V. / Povero, D. / Paternostro, C. / Mareschi, K. / Ferrero, I. / David, E. / Bertolani, C. / Caligiuri, A. et al. | 2011
- 975
-
Galectin-3 ablation protects mice from diet-induced NASH: A major scavenging role for galectin-3 in liverIacobini, C. / Menini, S. / Ricci, C. / Fantauzzi, C. B. / Scipioni, A. / Salvi, L. / Cordone, S. / Delucchi, F. / Serino, M. / Federici, M. et al. | 2011
- 984
-
Oleuropein attenuates hepatic steatosis induced by high-fat diet in micePark, S. / Choi, Y. / Um, S. J. / Yoon, S. K. / Park, T. et al. | 2011
- 994
-
Overexpression of the IGF2-mRNA binding protein p62 in transgenic mice induces a steatotic phenotypeTybl, E. / Shi, F. D. / Kessler, S. M. / Tierling, S. / Walter, J. / Bohle, R. M. / Wieland, S. / Zhang, J. / Tan, E. M. / Kiemer, A. K. et al. | 2011
- 1002
-
Targeting cholesterol at different levels in the mevalonate pathway protects fatty liver against ischemia-reperfusion injuryLlacuna, L. / Fernandez, A. / Montfort, C. V. / Matias, N. / Martinez, L. / Caballero, F. / Rimola, A. / Elena, M. / Morales, A. / Fernandez-Checa, J. C. et al. | 2011
- 1011
-
A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitisRatziu, V. / de Ledinghen, V. / Oberti, F. / Mathurin, P. / Wartelle-Bladou, C. / Renou, C. / Sogni, P. / Maynard, M. / Larrey, D. / Serfaty, L. et al. | 2011
- 1020
-
Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: Is there a link?Targher, G. / Chonchol, M. / Zoppini, G. / Abaterusso, C. / Bonora, E. et al. | 2011
- 1030
-
New assessment of hepatic encephalopathyCordoba, J. et al. | 2011
- 1041
-
Immunosuppression in liver transplant recipients with renal impairmentDuvoux, C. / Pageaux, G. P. et al. | 2011
- 1055
-
Liver transplantation using fatty livers: Always feasible?McCormack, L. / Dutkowski, P. / El-Badry, A. M. / Clavien, P. A. et al. | 2011
- 1063
-
Platelets arrive at the scene of fibrosisstudiesHernandez-Gea, V. / Friedman, S. L. et al. | 2011
- 1066
-
Drug enhanced autophagy to fight mutant protein overloadMehrpour, M. / Codogno, P. et al. | 2011
- 1069
-
NS5A inhibitors: A new breakthrough for the treatment of chronic hepatitis CAsselah, T. et al. | 2011
- 1073
-
Epithelial-to-mesenchymal transition and acquired resistance to sunitinib in a patient with hepatocellular carcinomaMarijon, H. / Dokmak, S. / Paradis, V. / Zappa, M. / Bieche, I. / Bouattour, M. / Raymond, E. / Faivre, S. et al. | 2011
- 1079
-
Skin autofluorescence is high in patients with cirrhosis - Further arguing for the implication of Advanced Glycation End ProductsMaury, E. / Vergniol, J. / Ledinghen, V. d. / Rigalleau, V. et al. | 2011
- 1080
-
Stage of portal vein thrombosisQi, X. / Han, G. / Bai, M. / Fan, D. et al. | 2011
- 1082
-
Revising consensus in portal hypertension:Report of the Baveno V Consensus Workshop on methodology of diagnosis and therapy in Portal HypertensionSarin, S. K. / Valla, D. C. / Franchis, R. d. et al. | 2011
- 1087
-
New protease inhibitors for HCV - Help is on the wayFusco, D. N. / Chung, R. T. et al. | 2011
- 1090
-
No need for a large belly to have NASHMachado, M. V. / Cortez-Pinto, H. et al. | 2011
- 1094
-
IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapyAbe, H. / Hayes, C. N. / Ochi, H. / Maekawa, T. / Tsuge, M. / Miki, D. / Mitsui, F. / Hiraga, N. / Imamura, M. / Takahashi, S. et al. | 2011
- 1102
-
High HIV prevalence in male patients with acute hepatitis A in the Rome metropolitan area, Italy 2002-2008Girardi, E. / Scognamiglio, P. / Sciarrone, M. R. / Loffredo, M. / Gnesivo, C. / Noto, P. / Antonucci, G. / Capobianchi, M. R. / Ippolito, G. et al. | 2011
- 1107
-
High viral load and deregulation of the progesterone receptor signaling pathway: Association with Hepatitis E-related poor pregnancy outcomeBose, P. D. / Das, B. C. / Kumar, A. / Gondal, R. / Kumar, D. / Kar, P. et al. | 2011
- 1114
-
Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infectionManns, M. P. / Bourliere, M. / Benhamou, Y. / Pol, S. / Bonacini, M. / Trepo, C. / Wright, D. / Berg, T. / Calleja, J. L. / White, P. W. et al. | 2011
- 1123
-
Association of caffeine intake and histological features of chronic hepatitis CCostentin, C. E. / Roudot-Thoraval, F. / Zafrani, E. S. / Medkour, F. / Pawlotsky, J. M. / Mallat, A. / Hezode, C. et al. | 2011
- 1130
-
Treatment of chronic hepatitis C patients with the NS3/4A protease inhibitor danoprevir (ITMN-191/RG7227) leads to robust reductions in viral RNA: A phase 1b multiple ascending dose studyForestier, N. / Larrey, D. / Guyader, D. / Marcellin, P. / Rouzier, R. / Patat, A. / Smith, P. / Bradford, W. / Porter, S. / Blatt, L. et al. | 2011
- 1137
-
Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utilityMartin, N. K. / Vickerman, P. / Foster, G. R. / Hutchinson, S. J. / Goldberg, D. J. / Hickman, M. et al. | 2011
- 1145
-
The relationship between endotoxemia and hepatic endocannabinoids in cirrhotic rats with portal hypertensionLin, H. C. / Yang, Y. Y. / Tsai, T. H. / Huang, C. M. / Huang, Y. T. / Lee, F. Y. / Liu, T. T. / Lee, S. D. et al. | 2011
- 1154
-
Magnetic resonance quantification of water and metabolites in the brain of cirrhotics following induced hyperammonaemiaMardini, H. / Smith, F. E. / Record, C. O. / Blamire, A. M. et al. | 2011
- 1161
-
Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta-blockers: A randomized controlled trialMishra, S. R. / Sharma, B. C. / Kumar, A. / Sarin, S. K. et al. | 2011
- 1168
-
Vitamin D3 up-regulated protein 1 deficiency accelerates liver regeneration after partial hepatectomy in miceKwon, H. J. / Won, Y. S. / Yoon, Y. D. / Yoon, W. K. / Nam, K. H. / Choi, I. P. / Kim, D. Y. / Kim, H. C. et al. | 2011
- 1177
-
Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesisGao, P. / Wong, C. C. / Tung, E. K. / Lee, J. M. / Wong, C. M. / Ng, I. O. et al. | 2011
- 1185
-
Characterization of the transcriptional signature of C/EBPbeta isoforms (LAP/LIP) in Hep3B cells: Implication of LIP in pro-survival functionsSaint-Auret, G. / Danan, J. L. / Hiron, M. / Blache, C. / Sulpice, E. / Tendil, S. / Daveau, M. / Gidrol, X. / Salier, J. P. et al. | 2011
- 1195
-
CD1d-restricted natural killer T cells contribute to hepatic inflammation and fibrogenesis in miceIshikawa, S. / Ikejima, K. / Yamagata, H. / Aoyama, T. / Kon, K. / Arai, K. / Takeda, K. / Watanabe, S. et al. | 2011
- 1205
-
Sphingosine 1-phosphate (S1P)/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motilityLi, C. / Zheng, S. / You, H. / Liu, X. / Lin, M. / Yang, L. / Li, L. et al. | 2011
- 1214
-
Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinaseBen-Shlomo, S. / Zvibel, I. / Shnell, M. / Shlomai, A. / Chepurko, E. / Halpern, Z. / Barzilai, N. / Oren, R. / Fishman, S. et al. | 2011
- 1224
-
An apoptosis panel for nonalcoholic steatohepatitis diagnosisTamimi, T. I. / Elgouhari, H. M. / Alkhouri, N. / Yerian, L. M. / Berk, M. P. / Lopez, R. / Schauer, P. R. / Zein, N. N. / Feldstein, A. E. et al. | 2011
- 1230
-
Direct effects of iodothyronines on excess fat storage in rat hepatocytesGrasselli, E. / Voci, A. / Canesi, L. / De Matteis, R. / Goglia, F. / Cioffi, F. / Fugassa, E. / Gallo, G. / Vergani, L. et al. | 2011
- 1237
-
Association of the hemochromatosis gene with pazopanib-induced transaminase elevation in renal cell carcinomaXu, C. F. / Reck, B. H. / Goodman, V. L. / Xue, Z. / Huang, L. / Barnes, M. R. / Koshy, B. / Spraggs, C. F. / Mooser, V. E. / Cardon, L. R. et al. | 2011
- 1244
-
Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposityFracanzani, A. L. / Valenti, L. / Bugianesi, E. / Vanni, E. / Grieco, A. / Miele, L. / Consonni, D. / Fatta, E. / Lombardi, R. / Marchesini, G. et al. | 2011
- 1250
-
Management of hepatitis C virus genotype 4: Recommendations of An International Expert PanelKhattab, M. A. / Ferenci, P. / Hadziyannis, S. J. / Colombo, M. / Manns, M. P. / Almasio, P. L. / Esteban, R. / Abdo, A. A. / Harrison, S. A. / Ibrahim, N. et al. | 2011
- 1263
-
The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammationPols, T. W. / Noriega, L. G. / Nomura, M. / Auwerx, J. / Schoonjans, K. et al. | 2011
- 1273
-
Progress in the development of preventive and therapeutic vaccines for hepatitis C virusTorresi, J. / Johnson, D. / Wedemeyer, H. et al. | 2011
- 1286
-
Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: Perspectives and challengesMichel, M. L. / Deng, Q. / Mancini-Bourgine, M. et al. | 2011
- 1297
-
The MELD score in patients awaiting liver transplant: Strengths and weaknessesBernardi, M. / Gitto, S. / Biselli, M. et al. | 2011
- 1307
-
Novel insights in the interplay between inflammation and metabolic diseases: A role for the pathogen sensing kinase PKRMarsollier, N. / Ferre, P. / Foufelle, F. et al. | 2011
- 1310
-
Surveillance for hepatocellular carcinoma in cirrhotic patients: From official recommendations to the real lifeTrinchet, J. C. et al. | 2011
- 1312
-
The evidence supports a viral aetiology for primary biliary cirrhosisMason, A. L. et al. | 2011
- 1315
-
The evidence does not support a viral etiology for primary biliary cirrhosisSelmi, C. et al. | 2011
- 1317
-
PI(3)K/PTEN/AKT pathwayPiguet, A. C. / Dufour, J. F. et al. | 2011
- 1320
-
Reply to the Letter to the Editor `Improving MELD for use in acute liver failure'Jochum, C. / Bechmann, L. / Canbay, A. et al. | 2011
- 1320
-
Improving MELD for use in acute liver failureMcPhail, M. J. et al. | 2011
- 1321
-
Propofol in patients with cirrhosis and minimal hepatic encephalopathySharma, P. / Singh, S. / Sharma, B. C. et al. | 2011
- 1323
-
Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: A role for ribavirin?Peron, J. M. / Dalton, H. / Izopet, J. / Kamar, N. et al. | 2011
- 1324
-
Reply to the Letter to the Editor `Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: A role for ribavirin?'Acharya, S. K. et al. | 2011
- 1325
-
Effect of treatment with polyunsaturated fatty acids on HCV- or diet-induced fatty liverComparcola, D. / Nobili, V. / Alisi, A. / Balsano, C. et al. | 2011
- 1326
-
Reply to the Letter to the Editor `Effect of treatment with polyunsatured fatty acids on HCV- or diet-induced fatty liver'Koike, K. / Miyoshi, H. / Yotsuyanagi, H. / Moriya, K. et al. | 2011
- I
-
Guide for Authors| 2011
- S3
-
6 SUBANALYSES OF THE TELAPREVIR LEAD-IN ARM IN THE REALIZE STUDY: RESPONSE AT WEEK 4 IS NOT A SUBSTITUTE FOR PRIOR NULL RESPONSE CATEGORIZATIONFoster, G. R. / Zeuzem, S. / Andreone, P. / Pol, S. / Lawitz, E. J. / Diago, M. / Roberts, S. / Pockros, P. J. / Younossi, Z. / Lonjon-Domanec, I. et al. | 2011
- S4
-
9 BOCEPREVIR RESISTANCE-ASSOCIATED VARIANTS (RAVS) ARE OBSERVED MORE FREQUENTLY IN HCV (GT1)-INFECTED PATIENTS WITH POOR RESPONSE TO PEGINTERFERON ALFA-2B/RIBAVIRINZeuzem, S. / Barnard, R. J. / Howe, J. A. / Ogert, R. A. / Ralston, R. / Boparai, N. / Brass, C. A. / Albrecht, J. K. / Burroughs, M. / Sniukiene, V. et al. | 2011
- S5
-
11 IMPACT OF IL28B GENOTYPE AND PRETREATMENT SERUM IP-10 IN TREATMENT-NAIVE GENOTYPE-1 HCV PATIENTS TREATED WITH TMC435 IN COMBINATION WITH PEGINTERFERONa-2A AND RIBAVIRIN IN PILLAR STUDYAerssens, J. / Fanning, G. / Scholliers, A. / Lenz, O. / Peeters, M. / De Srnedt, G. / Fried, M. et al. | 2011
- S6
-
13 SIMILAR SVR RATES IN IL28B CC, CT OR TT PRIOR RELAPSER PARTIAL- OR NULL-RESPONDER PATIENTS TREATED WITH TELAPREVIR/PEGINTERFERON/RIBAVIRIN: RETROSPECTIVE ANALYSIS OF THE REALIZE STUDYPol, S. / Aerssens, J. / Zeuzem, S. / Andreone, P. / Lawitz, E. J. / Roberts, S. / Younossi, Z. / Foster, G. R. / Focaccia, R. / Horban, A. et al. | 2011
- S7
-
15 OPEN-LABEL PROSPECTIVE RANDOMIZED 48 WEEK CLINICAL TRIAL: ROSIGLITAZONE VERSUS ROSIGLITAZONE AND METFORMIN (AVANDAMET) VERSUS ROSIGLITAZONE AND LOSARTAN IN THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)Torres, D. / Jones, F. J. / Shaw, J. / Williams, C. / Ward, J. A. / Harrison, S. A. et al. | 2011
- S9
-
20 LOSARTAN ALONE OR COMBINED WITH SIMVASTATIN IMPROVED VISCERAL ADIPOSE TISSUE AND INFLAMMATION IN HYPERTENSIVE NORMOCHOLESTEROLEMIC PATIENTS WITH NON-ALCOHOLIC HEPATIC STEATOSISFogari, R. / Mugellini, A. / Zoppi, A. / Lazzari, P. / Maffioli, P. / Derosa, G. et al. | 2011
- S10
-
22 ELECTROSTATIC MODIFICATIONS OF THE HLA-DR P9 PEPTIDE-BINDING POCKET AND SUSCEPTIBILITY TO PRIMARY SCLEROSING CHOLANGITISHov, J. R. / Kosmoliaptsis, V. / Traherne, J. A. / Olsson, M. / Boberg, K. M. / Bergquist, A. / Schrumpf, E. / Bradley, J. A. / Taylor, C. J. / Lie, B. A. et al. | 2011
- S11
-
24 AUTOTAXIN IS A NOVEL DIAGNOSTIC MARKER FOR INTRAHEPATIC CHOLESTASIS OF PREGNANCYKremer, A. E. / Dixon, P. H. / Ris-Stalpers, C. / Geenes, V. / Chambers, J. / van der Post, J. A. / Williamson, C. / Beuers, U. / Oude Elferink, R. P. et al. | 2011
- S12
-
26 NOTCH2 MUTATIONS IN ALAGILLE SYNDROMEKamath, B. M. / Hutchinson, A. / Bauer, R. / Gerfen, J. / Krantz, I. D. / Piccoli, D. A. / Spinner, N. B. / Loomes, K. M. et al. | 2011
- S15
-
33 LIVER TRANSPLANTATION FOR ERYTHROPOIETIC PROTOPORPHYRIA IN EUROPEWahlin, S. / Stal, P. / Adam, R. / Karam, V. / Porte, P. / Seehofer, D. / Gunson, B. K. / Hillingso, J. / Klempnauer, J. L. / Schmidt, J. et al. | 2011
- S18
-
40 COMPLETION OF HEPATITIS C VIRUS REPLICATION CYCLE IN HETEROKARYONS EXCLUDES DOMINANT RESTRICTION FACTORS IN HUMAN NON-LIVER AND MOUSE LIVER CELL LINESFrentzen, A. / Huging, K. / Bitzegeio, J. / Friesland, M. / Hoffmann, M. / Lindemann, D. / Zimmer, G. / Zielecki, F. / Weber, F. / Steinmann, E. et al. | 2011
- S21
-
48 HEPATOCYTE PROLIFERATION AFTER PARTIAL HEPATECTOMY IS ACCELERATED IN MYD88 NULL MICE DESPITE THE ABROGATION OF EARLY CYTOKINE ACTIVATIONVaquero, J. / Campbell, J. S. / Haque, J. / McMahan, R. S. / Bauer, R. L. / Fausto, N. et al. | 2011
- S22
-
50 PKA-DEPENDENT P-SER-675b-CATENIN PHOSPHORYLATION INCREASES CHOLANGIOCYTE MOTILITY IN PKHDDEL4/DEL4 MICE, A MODEL OF FIBROPOLYCYSTIC LIVER DISEASES CAUSED BY DEFECTIVE FIBROCYSTIN FUNCTIONSpirli, C. / Locatelli, L. / Fiorotto, R. / Morell, C. / Cadamuro, M. / Fabris, L. / Strazzabosco, M. et al. | 2011
- S23
-
53 PERICENTRAL DOWNREGULATION OF BSEP AND MRP2 FOLLOWING EXPERIMENTAL ISCHEMIA AND REPERFUSION IS RESTORED BY HBG200-MEDIATED PREINDUCTION OF HEME OXYGENASE-1Donner, M. G. / Topp, S. A. / Krienen, A. / Cebula, P. / Macher, A. / Gehrmann, T. / Pannen, B. H. / Knoefel, W. T. / Haussinger, D. et al. | 2011
- S26
-
58 LY-6C INTERMEDIATE AND LY-6C LO INTRAHEPATIC MACROPHAGE SUBSETS ORCHESTRATE RESOLUTION OF HEPATIC FIBROSIS FOLLOWING CHRONIC INJURYRamachandran, P. / Pellicoro, A. / Vernon, M. A. / Hartland, S. N. / Ali, A. / Aucott, R. L. / Forbes, S. J. / Iredale, J. P. et al. | 2011
- S28
-
63 CHARACTERIZATION OF VIROLOGIC ESCAPE IN HCV GENOTYPE 1 NULL RESPONDERS RECEIVING A COMBINATION OF THE NS3 PROTEASE INHIBITOR BMS-650032 AND NS5A INHIBITOR BMS-790052McPhee, F. / Hernandez, D. / Yu, F. / Ueland, J. / Wang, C. / Huang, H. / Gardiner, D. / Fridell, R. / Gao, M. et al. | 2011
- S32
-
72 TARGETED DELIVERY OF ANTI-VIRAL CYTOKINE TO HBVINFECTED CELLS USING T CELL RECEPTOR-LIKE ANTIBODIESJi, C. / Seetharama, S. / Tang, T. / Tei, T. C. / Tiefenthaler, G. / Lopatin, U. / Sankuratri, S. / Ma, H. / Theo, D. / Kennedy, P. et al. | 2011
- S33
-
74 NOVEL PEPTIDE-BASED MICROBIOCIDES INHIBITING HEPATITIS B VIRUS ENTRY BY PREVENTING VIRUS INTERACTION WITH THE CELL SURFACELucifora, J. / Kowalski, I. / Xia, Y. / Brandenburg, K. / Protzer, U. et al. | 2011
- S34
-
77 IMAGING MASS SPECTROMETRY PROVIDES FINGERPRINTS FOR DISTINGUISHING HEPATOCELLULAR CARCINOMA FROM CIRRHOSIS AND SUGGESTS AN UBIQUITIN RECYCLING DEFECT IN HEPATOCELLULAR CARCINOMALe Faouder, J. / Laouirem, S. / Chapelle, M. / Belghiti, J. / Degos, F. / Paradis, V. / Camadro, J. M. / Bedossa, P. et al. | 2011
- S36
-
81 GIDEON (GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN HCC AND OF ITS TREATMENT WITH SORAFENIB) STUDY FIRST INTERIM RESULTS: SORAFENIB DOSING ACROSS REGIONS AND DISEASE SUBGROUPSBronowicki, J. P. / Lencioni, R. / Venook, A. / Marrero, J. / Kudo, M. / Ye, S. L. / Nakajima, K. / Cihon, F. / Papandreou, C. et al. | 2011
- S38
-
86 ABSENCE OF PROTECTION IN INDIVIDUALS EXPOSED TO HEPATITIS C VIRUS DEMONSTRATES DISCRETE GENETIC PATHWAYS FOR PROTECTION AGAINST CHRONIC HCV INFECTIONKnapp, S. / Ho, K. M. / Warshow, U. / Heqazy, D. / Little, A. M. / Alexander, G. / Thursz, M. / Cramp, M. E. / Khakoo, S. I. et al. | 2011
- S39
-
88 ANTI-FIBROTIC IMMUNE-MODULATION EFFECTS OF 25-HYDROXY-VITAMIN D IN HCV AND MICE FIBROSIS MODELDoron, S. / Amer, J. / Abu-Tair, L. / Mahamid, M. / Abu-Mouch, S. / Safadi, R. et al. | 2011
- S40
-
91 FRATRICIDE OF HBV-SPECIFIC CD8 T CELLS BY NK CELLS MEDIATED THROUGH THE TRAIL PATHWAYPeppa, D. / Micco, L. / Schurich, A. / Nebbia, G. / Khanna, P. / Singh, H. / Rosenberg, W. / Dusheiko, G. / Gilson, R. / Maini, M. et al. | 2011
- S41
-
93 ATGL (PNPLA2) KNOCKOUT MICE ARE PROTECTED FROM HEPATIC ER-STRESS VIA OLEIC ACID ACCUMULATIONFuchs, C. D. / Claudel, T. / Kumari, P. / Stojakovic, T. / Haemmerle, G. / Halilbasic, E. / Gumhold, J. / Silbert, D. / Koefeler, H. / Zechner, R. et al. | 2011
- S42
-
96 VANIN-1 ACTIVITY MODULATES THE STEATOSISSTEATOHEPATITIS TRANSITION IN PROGRESSIVE NON-ALCOHOLIC STEATOHEPATITISConcas, D. / Wu, B. / Kudo, H. / Levene, A. / Thomas, H. C. / Goldin, R. D. / Thursz, M. R. / Anstee, Q. M. et al. | 2011
- S43
-
98 CIRCULATING HUMAN INFLAMMATORY CELL MICROPARTICLES (MP): A NOVEL TOOL TO ASSESS SEVERITY OF HEPATIC INFLAMMATION IN HEPATITIS C AND NASHKornek, M. / Lynch, M. / Exley, M. / Afdhal, N. H. / Schuppan, D. et al. | 2011
- S48
-
108 ASSOCIATION OF GENES REGULATING VITAMIN D HOMEOSTASIS WITH VITAMIN D LEVELS AND LIVER FIBROSIS IN A COHORT OF PATIENTS WITH CHRONIC LIVER DISEASEGrunhage, F. / Hochrath, K. / Krawczyk, M. / Obermayer-Pietsch, B. / Trauner, M. / Lammert, F. et al. | 2011
- S49
-
111 SARCOPENIA PREDICTS EARLY MORTALITY IN PATIENTS WITH CIRRHOSISMontano-Loza, A. J. / Meza-Junco, J. / Prado, C. / Lieffers, J. / Baracos, V. / Bain, V. / Sawyer, M. et al. | 2011
- S50
-
113 CIRRHOTIC CARDIOMYOPATHY MANIFESTED BY LEFT VENTRICLE DIASTOLIC DYSFUNCTION IS A RISK FACTOR IN THE DEVELOPMENT OF HEPATORENAL SYNDROME AND LOWER SURVIVALAchecar, L. / Gonzalez-Tallon, A. / Mesonero, F. / Perez-Lasala, J. / Tejedor, M. / Serradilla, R. / Ruiz-del-Arbol, L. et al. | 2011
- S51
-
116 STIMULATION OF LIVER REGENERATION AND AMELIORATION OF FIBROSIS BY ANTAGONISM OF A 5-HT2B/ERK/JUND/TGFb1 SIGNALING PATHWAY IN HEPATIC STELLATE CELLOakley, F. / Murphy, L. / Wright, M. / Mann, D. et al. | 2011
- S52
-
118 PROTECTIVE ADAPTATION TO LIVER FIBROSIS IN A SINGLE GENERATION BY HERITABLE EPIGENETIC MODIFICATIONSZeybel, M. / Oakley, F. / Burt, A. D. / Mann, D. A. / Mann, J. et al. | 2011
- S53
-
121 URSOLIC ACID AMELIORATES HEPATIC FIBROGENESIS THROUGH INDUCTION OF APOPTOSIS IN HEPATIC STELLATE CELLSIkejima, K. / Wang, X. / Kon, K. / Arai, K. / Fukuhara, K. / Hosoya, S. / Yamashina, S. / Watanabe, S. et al. | 2011
- S55
-
126 A PHASE-2B TRIAL TO EVALUATE THE SAFETY, TOLERABILITY AND EFFICACY OF A CASPASE INHIBITOR GS-9450, IN ADULTS FAILING PEG/RBV THERAPY FOR CHRONIC HCV INFECTIONManns, M. / Palmer, M. / Flisiak, R. / DeJesus, E. / Hazan, L. / Liang, W. / Oldach, D. / McHutchison, J. / Hirsch, K. et al. | 2011
- S56
-
128 DIAGNOSTIC PERFORMANCE OF TRANSIENT ELASTOGRAPHY (FIBROSCAN) TO IDENTIFY PATIENTS ELIGIBLE FOR ANTIVIRAL TREATMENT IN CHRONIC HEPATITIS BLeroy, V. / Adler, M. / Marcellin, P. / Sturm, N. / Moreno, C. / Bedossa, P. / Cheveau, A. / Zarski, J. P. / Asselah, T. et al. | 2011
- S57
-
130 CASPASE-8 ABLATION RESCUES SPONTANEOUS APOPTOSIS AND HEPATOCARCINOGENESIS IN NEMO-DEFICIENT MICE BUT TRIGGERS NON-APOPTOTIC LIVER INJURYLiedtke, C. / Bangen, J. M. / Freimuth, J. / Beraza, N. / Lambertz, D. / Cubero, F. J. / Karlmark, K. R. / Streetz, K. L. / Krombach, G. A. / Tacke, F. et al. | 2011
- S58
-
133 DYSREGULATION OF FIBROBLAST GROWTH FACTOR NETWORK IN EARLY HEPATOCELLULAR CARCINOMATovar, V. / Cornelia, H. / Hoshida, Y. / Toffanin, S. / Villanueva, A. / Sia, D. / Peix, J. / Lachenmayer, A. / Alsinet, C. / Sole, M. et al. | 2011
- S61
-
140 RELATIONSHIP BETWEEN CIRCULATORY DYSFUNCTION AND SEVERITY OF CARDIOMYOPATHY IN PATIENTS WITH CIRRHOSISAchecar, L. / Gonzalez-Tallon, A. / Mesonero, F. / Serradilla, R. / Milicua, J. M. / Ruiz-del-Arbol, L. et al. | 2011
- S63
-
145 DRIVING SIMULATION AND COGNITIVE TESTING CAN IMPROVE INSIGHT INTO IMPAIRED DRIVING SKILLS IN CIRRHOTIC PATIENTS WITH MHEBajaj, J. / Sanyal, A. / Sterling, R. / White, M. / Noble, N. / Bell, D. / Fuchs, M. / Stravitz, R. T. / Heuman, D. et al. | 2011
- S65
-
150 LIVER RELATED EVENTS AND SURVIVAL IN PATIENTS WITH COMPENSATED HCV CIRRHOSIS: THE ROLE OF SUSTAINED VIROLOGICAL RESPONSE TO PEG-IFN BASED THERAPY AND PORTAL HYPERTENSIONCalvaruso, V. / Di Marco, V. / Ferraro, D. / Pizzillo, P. / Alaimo, G. / Craxi, A. et al. | 2011
- S67
-
156 EFFECT OF RAMADAN FASTING ON MUSLIM PATIENTS WITH CHRONIC LIVER DISEASESElnadry, M. H. / Negm, I. A. / Abdel-aziz, I. M. / Elshafee, A. M. / El-azhary, S. S. / Abdelhafez, M. A. / Mohii, S. M. / Elteeby, D. M. et al. | 2011
- S68
-
158 RELIABILITY OF SERUM CREATININE IN ASSESSING RENAL FUNCTION IS DIMINISHED IN PATIENTS WITH CIRRHOSIS AS COMPARED WITH PATIENTS WITH ORGANIC RENAL DISEASEGarcovich, M. / Tsochatzis, E. / Georgadis, D. / Germani, G. / Fede, G. / Davenport, A. / Gasbarrini, A. / Burroughs, A. K. et al. | 2011
- S69
-
161 COLLAGEN PROPORTIONATE AREA: BEST INDEX TO PREDICT DECOMPENSATION IN PATIENTS WITH LIVER CIRRHOSIS OF DIFFERENT ETIOLOGIESIsgro, G. / Andreana, L. / Garcovich, M. / Luong, T. V. / Hall, A. / Manousou, P. / Goossens, N. / OBeirne, J. / Patch, D. / Dhillon, A. P. et al. | 2011
- S71
-
166 HEPATIC VEIN TRANSIT TIME USING A MICROBUBBLE CONTRAST ENHANCED ULTRASONOGRAPHY CAN ASSESS THE SEVERITY OF PORTAL HYPERTENSION NON-INVASIVELY IN CIRRHOTIC PATIENTSKim, M. Y. / Baik, S. K. / Jeon, H. K. / Park, H. J. / Park, S. Y. / Kim, B. R. / Hong, J. H. / Jo, K. W. / Kim, Y. J. / Cheon, G. J. et al. | 2011
- S73
-
171 INDOCYANINE GREEN AS A PREDICTOR OF CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN A PROSPECTIVE COHORT STUDY OF PATIENTS WITH CHRONIC LIVER DISEASELisotti, A. / Azzaroli, F. / Turco, L. / Buonfiglioli, F. / Ceciinato, P. / Calvanese, C. / Lodato, F. / Montagnani, M. / Golfieri, R. / Colecchia, A. et al. | 2011
- S74
-
174 FUNCTIONAL CORE MODULATION FOLLOWING TREATMENT OF MINIMAL HEPATIC ENCEPHALOPATHY WITH L-ORNITHINE L-ASPARTATE: A POTENTIAL NOVEL MECHANISM OF ACTIONMcPhail, M. J. / Leech, R. / Grover, V. P. / Fitzpatrick, J. / Dhanjal, N. S. / Saxby, B. K. / Wesnes, K. / Thomas, H. C. / Wise, R. J. / Taylor-Robinson, S. D. et al. | 2011
- S76
-
178 A PROSPECTIVE STUDY COMPARING THE DIFFERENT INDIRECT METHODS TO MEASURE PORTAL PRESSUREMaleux, G. / Willems, E. / Heye, S. / Laleman, W. / Verslype, C. / Nevens, F. et al. | 2011
- S78
-
183 PSYCHOMETRIC, WAKE- AND SLEEP-EEG FEATURES OF PATIENTS WITH CIRRHOSIS AND INDUCED HYPERAMMONAEMIARaduazzo, I. D. / Bersagliere, A. / Schiff, S. / Gatta, A. / Amodio, P. / Achermann, P. / Montagnese, S. et al. | 2011
- S79
-
186 EFFECT OF LOW MOLECULAR WEIGHT HEPARIN (LMWH) ON THROMBIN GENERATION IN CIRRHOTIC PATIENTS AT DIFFERENT STAGES OF LIVER DISEASERodriguez, K. I. / Rossetto, V. / Dabrilli, P. / Gavasso, S. / Radu, C. / Burra, P. / Simioni, P. / Senzolo, M. et al. | 2011
- S81
-
191 SPLENOHEPATIC INDEX IN ACOUSTIC RADIATION FORCE IMPULSE ELASTOGRAPHY (ARFI) CAN INCREASE THE ACCURACY FOR PORTAL HYPERTENSION PREDICTION IN CIRRHOTIC PATIENTS?Sporea, I. / Bota, S. / Sirli, R. / Popescu, A. / Danila, M. / Sendroiu, M. et al. | 2011
- S82
-
194 TIPS-PROCEDURE DOES NOT CHANGE ENDOTOXIN LEVELS IN BLOOD OF PATIENTS WITH ALCOHOLIC LIVER CIRRHOSISTrebicka, J. / Krag, A. / Gansweid, S. / Appenrodt, B. / Schiedermaier, P. / Sauerbruch, T. / Spengler, U. et al. | 2011
- S83
-
197 P73 JOINS P53 AS A REGULATOR OF MICRORNAS IN HEPATOCELLULAR CARCINOMABender, M. H. / Koenig, L. C. / Joschko, N. / Besenbeck, B. / Pschowski, R. / Stremmel, W. / Muller, M. et al. | 2011
- S84
-
199 AUTOANTIBODIES SCREENING BY PROTEIN MICROARRAY: AN INNOVATIVE SOURCE OF CIRCULATING DIAGNOSTIC MARKERS FOR HEPATOCELLULAR CARCINOMACantu, M. / Gualandi, A. / Genovese, F. / Bruschi, P. / Bolondi, L. / Chieco, P. et al. | 2011
- S85
-
201 COPY NUMBER ALTERATIONS IN HEPATOCELLULAR CARCINOMA AND IDENTIFICATION OF NUCKS1 AS A PUTATIVE ONCOGENE ON CHROMOSOME 1Q32.1Cheong, J. Y. / Kim, S. S. / Kim, D. K. / Yeo, M. / Woo, J. H. / Yang, S. J. / Yang, K. S. / Cho, S. W. et al. | 2011
- S86
-
204 IN VIVO RNAI SCREENING IDENTIFIES NEW MEDIATORS OF P53 INDEPENDENT TUMOR SUPPRESSIVE FUNCTIONS OF P19ARF IN THE LIVERDauch, D. / Wustefeld, T. / Kang, T. W. / Hohmeyer, A. / Rudalska, R. / Honicke, L. / Schirmacher, P. / Longerich, T. / Zender, L. et al. | 2011
- S87
-
207 BLOCKING THE HEDGEHOG PATHWAY ATTENUATES CARCINOGENESIS OF CHOLANGIOCELLULAR CARCINOMAEl Khatib, M. / Kalnytska, A. / Palagani, V. / Wilkens, L. / Manns, M. P. / Malek, N. P. / Plentz, R. R. et al. | 2011
- S89
-
212 SDF-1 ACTS MORE AS A CHEMOTACTIC AGENT THAN AS A SURVIVAL FACTOR ON THE INTERACTION OF HUMAN HEPATIC STELLATE CELLS (HHSC) AND CCA CELL LINESGentilini, A. / Rombouts, K. / Caligiuri, A. / Pinzani, M. et al. | 2011
- S90
-
215 CYCLOOXYGENASE-2, TUMOR NECROSIS FACTOR-a, VASCULAR ENDOTHELIAL GROWTH FACTOR-A AND IL-6 GENES SNPS AND IL-6 SERUM LEVELS IN LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMAGiannitrapani, L. / Giacalone, A. / Soresi, M. / Campagna, M. E. / La Spada, E. / Cervello, M. / Montalto, G. et al. | 2011
- S91
-
218 MIR141 AND MIR200C REGULATE PROGENITOR CELL FEATURES IN HEPATOCELLULAR CARCINOMASGovaere, O. / Berkers, J. / van Kempen, L. / Van den Eynde, K. / Komuta, M. / Spee, B. / Aerts, R. / Topal, B. / Nevens, F. / Lerut, E. et al. | 2011
- S92
-
221 A MURINE AND HUMAN STUDY DEMONSTRATING THE ROLE OF PLGF IN HEPATOCELLULAR CARCINOMAHeindryckx, F. / Coulon, S. / Crape, L. / Cornelis, G. / Libbrecht, L. / Geerts, A. / Colle, I. / Van Vlierberghe, H. et al. | 2011
- S95
-
230 METABOLIC GENES IN HEPATOCELLULAR CARCINOMAKohjima, M. / Yada, R. / Taketomi, A. / Gotoh, K. / Yoshimoto, T. / Fukushima, N. / Fukuizumi, K. / Kawabe, K. / Mizutani, T. / Harada, N. et al. | 2011
- S97
-
235 MODULATION OF ERK PHOSPHORYLATION BY GINSENG EXTRACT (GE) AFFECTS SORAFENIB SUSCEPTIBILITY IN HUMAN CANCER CELL LINES AND IN VIVO ANIMAL MODELLee, N. H. / Kim, M. K. / Park, H. J. / Rho, J. S. / Woo, H. Y. / Heo, J. / Yoon, G. T. / Cho, M. / Hwang, T. H. et al. | 2011
- S99
-
240 HEPATOCELLULAR CARCINOMA CELL LINES SECRETOME AS A SOURCE OF POTENTIAL BIOMARKERSMinguzzi, M. / Genovese, F. / Gualandi, A. / Giovannini, C. / Bruschi, P. / Cantu, M. / Chieco, P. / Gramantieri, L. / Bolondi, L. et al. | 2011
- S100
-
243 REDOX-DEPENDENT INDUCTION OF EPITHELIAL TO MESENCHYMAL TRANSITION AND INCREASED INVASIVENESS BY ONCOSTATIN M IN HEPATIC CANCER CELLSPaternostro, C. / Caimito, S. / Novo, E. / Busletta, C. / Povero, D. / David, E. / Colombatto, S. / Parola, M. et al. | 2011
- S101
-
246 NUCLEAR TRANSLOCATION OF C-JUN AND MALIGNANT POTENTIAL IN HEPATOCELLULAR CARCINOMA PATIENTS UNDERGOING ORTHOTOPIC LIVER TRANSPLANTATIONRohr-Udilova, N. / Sieghart, W. / Eferl, R. / Peck-Radosavljevic, M. et al. | 2011
- S102
-
249 CHANGES IN TUMOR STIFFNESS FOR EARLY PREDICTION OF TUMOR RESPONSE TO SORAFENIB: A PROOF-OF-CONCEPT STUDY WITH ELASTOSONOGRAPHY IN AN ANIMAL MODEL OF HEPATOCELLULAR CARCINOMA (HCC)Salvatore, V. / Baron Toaldo, M. / Marinelli, S. / Palama, C. / Gramantieri, L. / Cipone, M. / Bolondi, L. / Piscaglia, F. et al. | 2011
- S104
-
254 DOWNREGULATION OF CYCLIN-CDK COMPLEX BY (SNAC) IN HUMAN HEPATOCELLULAR CANCER CELLSStefano, J. T. / Bellodi-Privato, M. / Cogliati, B. / Souza, G. F. / Oliveira, M. G. / Silva, T. C. / Lima, V. M. / Oliveira, E. R. / DAlbuquerque, L. A. / Carrilho, F. J. et al. | 2011
- S105
-
256 DKK2 DELETION RESULTS IN ENHANCED LIVER CANCER DEVELOPMENTMaass, T. / Sfakianakis, I. / Westphal, H. / Galle, P. R. / Teufel, A. et al. | 2011
- S107
-
261 LONG-TERM SORAFENIB EXPOSURE IN HEPATOCELLULAR CANCER CELL LINES: RESISTANCE, RISK OF REBOUND GROWTH AND EPITHELIAL TO MESENCHYMAL TRANSITIONvan Malenstein, H. / Verslype, C. / Windmolders, P. / Libbrecht, L. / Nevens, F. / van Pelt, J. et al. | 2011
- S108
-
264 COMMON GENETIC VARIATION IN NATURAL KILLER CELL RECEPTOR PROTEIN G2D DOES NOT MODIFY SUSCEPTIBILITY TO SPORADIC CHOLANGIOCARCINOMAWadsworth, C. A. / Dixon, P. H. / Zabron, A. A. / Wong, J. H. / Chapman, M. H. / McKay, S. C. / Spalding, D. R. / Pereira, S. P. / Wasan, H. S. / Thomas, H. C. et al. | 2011
- S109
-
266 TAX1BP1 LIMITS TUMOR FORMATION IN EXPERIMENTAL LIVER CANCERWaidmann, O. / Piiper, A. / Zeuzem, S. / Dikic, I. et al. | 2011
- S110
-
269 CHARACTERISATION OF PATHOGEN RECOGNITION RECEPTORS IN AN HEPATOCYTE CELL LINE (HEPARG CELLS)Ait-goughoulte, M. / Luangsay, S. / Gruffaz, M. / Fletcher, S. / Tommasino, M. / Durante, D. / Zoulim, F. et al. | 2011
- S111
-
272 DETECTION OF A HCV-SPECIFIC CYTOTOXIC RESPONSE DURING THE FIRST TWELVE WEEKS OF ANTI-HCV TREATMENT CORRELATES WITH SUSTAINED VIROLOGIC RESPONSELarrubia, J. R. / Benito, S. / Lokhande, M. / Miquel, J. / Calvino, M. / Sanz-de-Villalobos, E. / Gonzalez-Praetorious, A. / Albertos, S. / Garcia-Garzon, S. / Parra-Cid, T. et al. | 2011
- S112
-
275 DEVELOPMENT OF A HIGH THROUGHPUT 2-DIMENSIONAL COMBINATORIAL EXPANSION ASSAY FOR THE IN VITRO RESCUE OF EXHAUSTED HBV-SPECIFIC T CELLSTan, A. T. / Chia, A. / Ho, Z. Z. / Bertoletti, A. et al. | 2011
- S114
-
280 AN INCREASED AND ACTIVATED VDELTA1 POPULATION CHARACTERISES PATIENTS WITH ACTIVE AND ADVANCED HCV-RELATED LIVER DISEASEFerri, S. / Lanzoni, G. / Lalanne, C. / Bassi, M. / Cicola, R. / Belardinelli, A. / Ballardini, G. / Muratori, P. / Pappas, G. / Muratori, L. et al. | 2011
- S115
-
283 TRACING THE DYNAMICS OF T-CELL SUBSETS IN DIFFERENT PHASES OF HBEAG NEGATIVE CHRONIC HBV INFECTIONGhosh, S. / Das, K. / Nandi, M. / Mukhopadhyay, D. / Banerjee, P. / Mondai, R. K. / Pandit, P. / Santra, A. / Banerjee, S. / Chatterjee, M. et al. | 2011
- S116
-
286 DOMINANT CYTOLYTIC ANTIVIRAL EFFECTOR FUNCTIONS IN A NOVEL IMMUNOLOGICAL MODEL OF HBV INFECTIONGrimm, P. / Heeg, M. / Kersting, N. / Blum, H. E. / Bertoletti, A. / Thimme, R. et al. | 2011
- S117
-
288 CO-INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS (HIV) RESULTS IN HIGHER LEVEL OF REGULATORY T CELLS (TREG) IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV) INFECTIONHartling, H. J. / Gaardbo, J. / Knudsen, L. S. / Ullum, H. / Vainer, B. / Bruunsgaard, H. / Clausen, M. / Gerstoft, J. / Nielsen, S. D. et al. | 2011
- S118
-
291 TOLL-LIKE RECEPTOR 3, 7/8 AND 9 FUNCTION IS IMPAIRED IN HEPATITIS C PATIENTS WITH RAPID FIBROSIS POST LIVER TRANSPLANTHowelP, J. / Sawhney, R. / Skinner, N. / Markovska, V. / Testro, A. / Gow, P. / Angus, P. / Visvanathan, K. et al. | 2011
- S119
-
294 ALTERED SURFACE EXPRESSION AND CYTOLYTIC FUNCTION OF NATURAL KILLER CELLS IN HEPATITIS C VIRUS INFECTIONJiang, Y. F. / Pan, Y. / Feng, J. Y. / Niu, J. Q. et al. | 2011
- S121
-
299 EXPRESSION OF THE 2B4 ADAPTOR MOLECULE SAP AS A DETERMINANT FOR CD8+ T CELL FUNCTION AND DYSFUNCTION IN VIRAL HEPATITISLunemann, S. / Suneetha, P. V. / Jaroszewicz, J. / Grabowski, J. / Pischke, S. / Helfritz, F. / Bektas, H. / Manns, M. P. / Cornberg, M. / Wedemeyer, H. et al. | 2011
- S122
-
302 DEXAMETHASONE COULD NOT REVERSE THE INHIBITORY AND CALCINEURIN INDEPENDENT EFFECT OF CYCLOSPORIN A ON CD4+CD25+ REGULATORY T CELLS ACTIVITYMiroux, C. / Vausselin, T. / Conti, F. / Calmus, Y. / Pancre, V. / Delhem, N. et al. | 2011
- S123
-
305 THE NOVEL KCTD9 CONTRIBUTES TO IMMUNOLOGICALLY MEDIATED LIVER INJURY THROUGH NK CELL ACTIVATION IN VIRUS INDUCED LIVER FAILUREChen, T. / Zhou, Y. / Zhu, L. / Pi, B. / Liu, X. / Luo, X. / Ning, Q. et al. | 2011
- S124
-
308 PROINFLAMMATORY AND PROANGIOGENIC MONOCYTE SUBSETS ARE INCREASED IN PERIPHERAL BLOOD OF PATIENTS WITH CHRONIC HEPATITIS CRodriguez-Munoz, Y. / Martin-Vilchez, S. / Borque, M. J. / Lopez-Rodriguez, R. / Trapero-Marugan, M. / Hernandez-Bartolome, A. / Moreno-Otero, R. / Sanz-Cameno, P. et al. | 2011
- S125
-
311 HLA-B07-POSITIVE INDIVIDUALS FROM A COMMON SOURCE HCV OUTBREAK ARE PREFERENTIALLY INFECTED BY A VIRAL VARIANT WITH A SUBSTITUTION IN AN HLA-B7-RESTRICTED CD8 EPITOPERuhl, M. / Ziegler, S. / Nattermann, J. / Spengler, U. / Timm, J. et al. | 2011
- S126
-
314 APPLICATION OF RECOMBINANT HUMAN INTERLEUKIN 2 IN THE TREATMENT OF CHILDREN WITH CHRONIC HEPATITIS CVolynets, G. / Pakhomovskaya, N. / Potapov, A. et al. | 2011
- S127
-
317 IDENTIFICATION OF THE DUCK INTERLEUKIN-10 RECEPTOR-1 AND EXPRESSION ANALYSIS OF NOVEL INTERLEUKIN-10 ISOFORMS IN THE DUCK HEPATITIS B MODELYao, Q. / Fischer, K. P. / Tyrrell, D. L. / Gutfreund, K. S. et al. | 2011
- S128
-
320 THE VALUE OF A NEW SCORE (PREDICTION LIVER FIBROSIS SCORE - PLF SCORE) FOR THE ASSESSMENT OF FIBROSIS IN CHRONIC HCV HEPATITISBota, S. / Sirli, R. / Sporea, I. / Focsa, M. / Popescu, A. / Danila, M. / Strain, M. / Sendroiu, M. / Deleanu, A. / Tudora, A. et al. | 2011
- S130
-
325 NON-INVASIVE DIAGNOSIS OF CIRRHOSIS IN CLINICAL PRACTICE IN HEPATITIS CCales, P. / Boursier, J. / Oberti, F. / Fouchard-Hubert, I. / Chaigneau, J. / de Ledinghen, V. / Zarski, J. P. / Rouselet, M. C. et al. | 2011
- S131
-
328 CIRCULATING BONE MARROW DERIVED FIBROCYTES CONTRIBUTE TO THE EXPANSION OF MYO-FIBROBLAST POOL IN HCV-MEDIATED LIVER FIBROSISEl Bassiouny, A. E. / El-Ahwany, E. G. / Zoheiry, M. K. / Nosseir, M. M. / Ibrahim, R. A. / Ibrahim, I. M. / Zada, S. K. / El-Bassiouni, N. E. et al. | 2011
- S132
-
330 ACOUSTIC RADIATION FORCE IMPULSE-IMAGING FOR NON-INVASIVE ASSESSMENT OF LIVER FIBROSIS: A POOLED META-ANALYSISFriedrich-Rust, M. / Nierhoff, J. / Lupsor, M. / Sporea, I. / Fierbinteanu-Braticevici, C. / Strobel, D. / Takahashi, H. / Yoneda, M. / Suda, T. / Zeuzem, S. et al. | 2011
- S133
-
333 THE USEFULLNESS OF VS/PLT: A NEW MARKER OF LIVER FIBROSISSong, C. / Hiramatsu, N. / Oze, T. / Yamada, R. / Inoue, Y. / Kurokawa, M. / Yakushijin, T. / Mochizuki, K. / Kiso, S. / Kanto, T. et al. | 2011
- S134
-
336 LIVER STIFFNESS DURING PREGNANCYKohlhaas, A. / Millonig, G. / Schutz, F. / Seitz, H. K. / Mueller, S. et al. | 2011
- S135
-
339 GENOMIC PROFILE AND FUNCTIONAL CHARACTERIZATION OF FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS BXu, M. Y. / Cm, Y. / Dong, Y. W. / Wang, Y. / Cai, X. B. / Lu, L. G. et al. | 2011
- S136
-
341 PERFORMANCE OF THE FIBROSCAN XL PROBE FOR LIVER STIFFNESS MEASUREMENT IN OBESE PATIENTS: A MULTICENTER VALIDATION STUDYMyers, R. P. / Pomier-Layrargues, G. / Duarte-Rojo, A. / Wong, D. K. / Beaton, M. D. / Levstik, M. A. / Kirsch, R. / Pollett, A. / Elkashab, M. et al. | 2011
- S137
-
344 WHICH ARE THE TECHNICAL PARAMETERS THAT MAKE ACOUSTIC RADIATION FORCE IMPULSE ELASTOGRAPHY (ARFI) A RELIABLE METHOD FOR LIVER STIFFNESS EVALUATION?Popescu, A. / Bota, S. / Sporea, I. / Sirli, R. / Danila, M. / Sendroiu, M. et al. | 2011
- S139
-
347 HEALTHY RANGES FOR SERUM ALANINE AMINOTRANSFERASE CONCENTRATION: TIME FOR A NEW UPDATE?Prati, P. / Cappiello, F. / Berzuini, A. / Spreaflco, M. / Guarnori, I. / Raffaele, L. / Bonato, C. / Duca, P. / Colli, A. et al. | 2011
- S140
-
350 TRANSIENT ELASTOGRAPHY (FIBROSCAN) IN PATIENTS WITH CHRONIC HEPATITIS B IN EVERYDAY CLINICAL PRACTICESinakos, E. / Manolakopoulos, S. / Papatheodoridis, G. / Papalavrentios, L. / Papageorgiou, M. V. / Papachrysos, N. / Hytiroglou, P. / Akriviadis, E. et al. | 2011
- S142
-
355 APPLYING HEPATITIS B GUIDELINES IN EUROPE: HOW EXPENSIVE IS A STATE-OF-THE ART MANAGEMENT OF HBV INFECTION?Becker, H. / Stahmeyer, J. / Heidelberger, S. / Deterding, K. / Krauth, C. / Cornberg, M. / Manns, M. P. / Wedemeyer, H. et al. | 2011
- S144
-
360 DEFINITION OF INACTIVE HEPATITIS B CARRIER BY SERUM HBSAG AND HBV DNA LEVELS - A LONG-TERM FOLLOW-UP STUDY ON HBSAG SEROCLEARANCEChan, H. L. / Wong, G. L. / Tse, C. H. / Chan, H. Y. / Wong, V. W. et al. | 2011
- S145
-
362 SERUM HEPATITIS B SURFACE ANTIGEN LEVEL IS ASSOCIATED WITH LIVER FIBROSIS IN PATIENTS WITH HBEAG-POSITIVE CHRONIC HEPATITIS BCheng, P. N. / Tsai, H. W. / Chang, T. T. et al. | 2011
- S146
-
365 INACTIVE HBV CARRIERS: IS LIVER STIFFNESS MEASUREMENT USEFUL? A MULTICENTRE PROSPECTIVE STUDYde Ledinghen, V. / Serejo, F. / Coco, B. / Oberti, F. / Han, K. / Pop, S. / Ollivier, I. / Laleman, W. / Friedrich-Rust, M. / Canva, V. et al. | 2011
- S147
-
367 DETERMINATION OF APOPTOTIC ACTIVITY IN UNTREATED CHRONIC HEPATITIS B VIRUS INFECTED PATIENTS WITH DIFFERENT BASELINE VIRAL LOADFarnik, H. / Lange, C. M. / Berger, A. / Sarrazin, C. / Herrmann, E. / Zeuzem, S. / Kronenberger, B. et al. | 2011
- S149
-
372 HEPATITIS B REACTIVATION FOLLOWING KIDNEY TRANSPLANTATION: INCIDENCE AND RISK FACTORSHassoun, Z. / Kabamba, B. / Marechal, C. / Goffin, E. / Kanaan, N. et al. | 2011
- S150
-
375 GENERATION OF THE PREDICTION MODELS FOR THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B AND EXTERNAL VALIDATION BY INDEPENDENT COHORTSKurosaki, M. / Yuen, M. F. / Seto, W. K. / Kumada, T. / Tanaka, K. / Suzuki, Y. / Hoshioka, Y. / Tamaki, N. / Kato, T. / Yasui, Y. et al. | 2011
- S151
-
378 SYNERGISTIC EFFECTS OF A1896, T1653 AND T1762/A1764 MUTATIONS IN GENOTYPE C2 HEPATITIS B VIRUS GENOME ON THE OCCURRENCE OF HEPATOCELLULAR CARCINOMALyu, H. / Chung, Y. H. / Kim, J. A. / Lee, D. / Lee, J. H. / Mathews, P. / Jin, Y. J. / Park, W. / Jaffee, E. / Zheng, L. et al. | 2011
- S152
-
380 REACTIVATION OF HEPATITIS B VIRUS IN HBSAG NEGATIVE PATIENTS UNDERGOING CHEMOTHERAPY FOR LYMPHOMA AND MULTIPLE MYELOMA: PROSPECTIVE SINGLE-INSTITUTION STUDYMatsui, T. / Kang, J. H. / Yane, K. / Kin, T. / Shida, H. / Tsuji, K. / Maguchi, H. / Andoh, S. / Sakai, H. et al. | 2011
- S154
-
385 SIGNIFICANCE OF TRANSIENT ELASTOGRAPHY (TE) IN HBEAG-NEGATTVE CHRONIC HBV CARRIERSPapatheodoridis, G. V. / Margariti, E. / Papageorgiou, M. V. / Kranidioti, H. / Katoglou, A. / Striki, A. / Kaflri, G. / Manolakopoulos, S. et al. | 2011
- S155
-
388 DIFFERENT LEVELS OF HDV-RNA AND HBV-DNA AND DIFFERENT EXPRESSION OF HBSAG ARE ASSOCIATED TO DIFFERENT OUTCOMES IN CHRONIC HDV INFECTIONRomeo, R. / Foglieni, B. / Raffaele, L. / Spreafico, M. / Prati, D. / Colombo, M. et al. | 2011
- S157
-
393 CHANGING OF GENOTYPES AND MOLECULAR EPIDEMIOLOGY OF SPREADING SUBGENOTYPE AE OF HEPATITIS B VIRUS AMONG PATIENTS WITH ACUTE HEPATITIS B IN JAPANTamada, Y. / Yatsuhashi, H. / Yano, K. / Nakamuta, M. / Masaki, N. / Mita, E. / Komatsu, T. / Watanabe, Y. / Muro, T. / Shimada, M. et al. | 2011
- S158
-
396 ELEVATED CPG ISLAND METHYLATION OF IL-17 PROMOTER IN ACUTE-ON-CHRONIC HEPATITIS B LIVER FAILUREWang, K. / Fan, Y. C. / Ge, J. / Fan, X. P. / Wang, B. / Han, L. Y. / Chen, L. Y. et al. | 2011
- S159
-
399 DELTA VIRUS COINFECTION DOES NOT INCREASE, BUT HCV COINFECTION INCREASE THE HBSAG LOSS, IN CHRONIC HBV INFECTIONYapali, S. / Bayrakci, B. / Gunsar, F. / Ersoz, G. / Karasu, Z. / Akarca, U. S. et al. | 2011
- S163
-
407 EARLY ON-TREATMENT HAEMATOLOGICAL PARAMETERS AND GENOTYPE PREDICT RESPONSE TO PEGYLATED INTERFERON AND RIBAVIRIN COMBINATION THERAPY IN CHRONIC HEPATITIS C CIRRHOSISCarey, I. / Mendes, A. / Joshi, D. / Gera, A. / Knighton, S. / Al-Freah, M. / Suddle, A. / Agarwal, K. et al. | 2011
- S167
-
415 TELAPREVIR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN INCREASED SUSTAINED VIROLOGIC RESPONSE RATES IN TREATMENT-NAIVE PATIENTS REGARDLESS OF RACE OR ETHNICITYDusheiko, G. M. / Fried, M. W. / Reddy, R. / Nelson, D. R. / Bzowej, N. / Adda, N. / Wright, C. I. / Bengtsson, L. / George, S. / Flamm, S. L. et al. | 2011
- S168
-
418 UTILITY OF HISTORICAL DATA COMPARED TO LEAD-IN RESPONSE IN PREDICTING SUSTAINED VIROLOGIC RESPONSE IN NON-RESPONDERS AND RELAPSERS TO PEGINTERFERON/RIBAVIRIN WHEN RE-TREATED WITH BOCEPREVIR+PEGINTERFERON ALFA-2B/RIBAVIRIN (P/R)Esteban, R. / Gordon, S. / Lawitz, E. / Marcellin, P. / Vierlin, J. / Zeuzem, S. / Poordad, F. / Boparai, N. / Burroughs, M. / Albrecht, J. et al. | 2011
- S169
-
420 INTERLEUKIN-28B POLYMORPHISMS, IP-10 AND VIRAL LOAD PREDICT VIROLOGICAL RESPONSE TO THERAPY IN CHRONIC HEPATITIS C UNDER REAL-LIFE CONDITIONSFattovich, G. / Covolo, L. / Bibert, S. / Askarieh, G. / Lagging, M. / Clement, S. / Malerba, G. / Pasino, M. / Guido, M. / Puoti, M. et al. | 2011
- S170
-
422 PROJECTING THE CLINICAL IMPACT OF THERAPEUTIC REGIMENS INCLUDING BOCEPREVIR IN PREVIOUSLY UNTREATED ADULT SUBJECTS WITH CHRONIC HEPATITIS C GENOTYPE 1Ferrante, S. / Chhatwal, J. / Dasbach, E. J. / El Khoury, A. / Sniukiene, V. / Poordad, F. F. / Bronowicki, J. P. / Brass, C. A. et al. | 2011
- S171
-
424 RESPIRATORY ALTERATIONS IN GENOTYPE 2/3 CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGYLATED INTERFERON OR ALBINTERFERON-ALFA-2B PLUS RIBAVIRIN IN A RANDOMIZED STUDYFoster, G. / Flisiak, R. / Chuang, W. L. / George, J. / Rasenack, J. / Sood, A. / Komolmit, P. / Thongsawat, S. / Tanwandee, T. / Sola, R. et al. | 2011
- S173
-
428 ADHERENCE TO ASSIGNED DOSING REGIMEN AND SUSTAINED VIROLOGIC RESPONSE AMONG HEPATITIS C GENOTYPE 1 TREATMENT-NAIVE AND PEG/RIBAVIRIN TREATMENT-FAILURES TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRINGordon, S. C. / Lawitz, E. J. / Bacon, B. R. / Sulkowski, M. S. / Yoshida, E. M. / Davis, M. / Boparai, N. / Sniukiene, V. / Burroughs, M. / Brass, C. A. et al. | 2011
- S174
-
430 INITIAL PK/PD ANALYSIS OF HIGH-DOSE NON-PEGYLATED INTERFERON ALPHA-2B ADMINISTERED BY CONTINUOUS SUBCUTANEOUS INFUSION TO THERAPY-NAIVE PATIENTS CHRONICALLY INFECTED WITH HCV GENOTYPE 1Grovender, E. A. / Lande, J. / Mische, S. / Van Antwerp, B. et al. | 2011
- S175
-
432 FIBROSIS STAGING PREDICTS VIROLOGICAL RESPONSE IN HEPATITIS C GENOTYPE 1 PATIENTS: INTERIM DATA FROM THE PROPHESYS TRIALHorban, A. / Rodriguez-Torres, M. / Cheinquer, H. / Curescu, M. / Pol, S. / Silva, G. F. / Orlandini, A. / Lee, S. S. / Ascione, A. / Messinger, D. et al. | 2011
- S178
-
439 EVALUATION OF LONG-TERM GLYCYRRHIZIN ADMINISTRATION IN CHRONIC HEPATITIS C - IS CONTROL OF ALT TO <50 IU/ML AN INDEX OF PREVENTION FOR DISEASE PROGRESSION?Kobayashi, M. / Suzuki, M. / Yamada, N. / Okamoto, M. / Ikeda, H. / Fukuda, Y. / Nagase, Y. / Takahashi, H. / Matsunaga, K. / Ishii, T. et al. | 2011
- S180
-
444 SVR FOR CONTROLLED-RELEASE INTERFERON ALPHA-2B (CR2B) +RIBAVIRIN COMPARED TO PEGYLATED INTERFERON ALPHA-2B (PEG2B) +RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE-1 (G1) HEPATITIS C: FINAL RESULTS FROM SELECT-2Lawitz, E. / Younossi, Z. / Mehra, R. / Rigney, A. / Krastev, Z. / Tchernev, K. / Takov, D. / Long, W. A. et al. | 2011
- S181
-
446 TIMING AND FREQUENCY OF DEPRESSION DURING HCV-TREATMENT WITH CONTROLLED-RELEASE-IFNA2B (CR2B) VS. PEGYLATED-IFNA2B (PEG2B): RESULTS FROM SELECT-2, A RANDOMIZED-OPEN-LABEL-72-WEEK-COMPARISON IN 116 TREATMENT-NAIVE PATIENTS WITH GENOTYPE-1 HCVLong, W. A. / Younossi, Z. / Lawitz, E. / Kotsev, I. / Takov, D. / Tchernev, K. / Rigney, A. / Ghalib, R. / Stoinov, S. / Balabanska, R. et al. | 2011
- S182
-
448 RESPONSE-GUIDED THERAPY WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN REDUCES DURATION IN NAIVE AND PEGINTERFERON ALFA-2B/RIBAVIRIN PREVIOUS-TREATMENT-FAILURE PATIENTS WITH HCV GENOTYPE 1Manns, M. P. / Poordad, F. / Bacon, B. R. / Bruno, S. / Esteban, R. / Silva, M. / Buti, M. / Burroughs, M. / Sniukiene, V. / Boparai, N. et al. | 2011
- S183
-
451 TELAPREVIR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN: ANALYSES OF PRE-DEFINED SUBPOPULATIONS IN THE PHASE 3 ADVANCE TRIALMarcellin, P. / Jacobson, I. M. / Zeuzem, S. / Bzowej, N. / Muir, A. J. / Dusheiko, G. / Reddy, R. / Adda, N. / Bengtsson, L. / Kauffman, R. S. et al. | 2011
- S184
-
453 SIGNATURE RESISTANCE MUTATIONS TO DIRECTLY ACTING ANTIVIRAL AGENTS OCCUR AT LOW PREVALENCE IN TREATMENT NAIVE SUBJECTS WITH RECENTLY ACQUIRED HEPATITIS C INFECTIONGaudieri, S. / Applegate, T. / Tshochner, M. / Plauzolles, A. / Pfafferott, K. / Lucas, M. / Diepolder, H. / Ulsenheimer, A. / Mallal, S. / Grebely, J. et al. | 2011
- S186
-
458 FINAL RESULTS OF THE PHARMACOKINETICS, EFFICACY, AND SAFETY/TOLERABILITY OF 400 AND 600 MG ONCE-DAILY DOSING OF ACH-1625 (HCV NS3 PROTEASE INHIBITOR) IN HCV GENOTYPE 1Detishin, V. / Haazen, W. / Hooijmaijers, R. / Ruppert, M. / Bol, K. / Robison, H. / Robarge, L. / Agarwal, A. / Deshpande, M. / Olek, E. et al. | 2011
- S189
-
465 TREATMENT OF HCV COMPENSATED CIRRHOTIC PATIENTS IS EQUALLY EFFECTIVE BEFORE AND AFTER LIVER TRANSPLANTATIONPonziani, F. R. / Annicchiarico, E. B. / Siciliano, M. / Pompili, M. / Gasbarrini, A. et al. | 2011
- S190
-
467 LONGTERM BENEFITS OF SUSTAINED VIROLOGICAL RESPONSE (SVR) IN PATIENTS WITH CHRONIC HEPATITIS C (CHC) VIRUS INFECTION: THE GERMAN LOTOS STUDYReimer, J. / Hueppe, D. / Sandow, P. / Naumann, U. / Goelz, J. / Christensen, S. / Busch, H. / Lutz, T. / Hey, K. H. / Gruengreiff, K. et al. | 2011
- S191
-
469 ITPA GENE VARIANT PROTECTS AGAINST TREATMENT-INDUCED ANEMIA AND IMPROVES VIRAL CLEARANCE BY PEGYLATED INTERFERON-ALFA AND RIBAVIRIN THERAPY IN CHRONIC HEPATITIS C PATIENTSSakamoto, N. / Tanaka, Y. / Nakagawa, M. / Yatsuhashi, H. / Nishiguchi, S. / Enomoto, N. / Azuma, S. / Nishimura-Sakurai, Y. / Kakinuma, S. / Nishida, N. et al. | 2011
- S192
-
471 EFFECTS OF SNP RS6051702 POLYMORPHISM ON ANEMIA AND TREATMENT OUTCOME IN CHRONIC HEPATITIS C GENOTYPE 1 PATIENTSScherzer, T. M. / Stauber, R. / Staettermayer, A. F. / Zinober, K. / Maieron, A. / Strasser, M. / Laferl, H. / Rutter, K. / Beinhardt, S. / Datz, C. et al. | 2011
- S194
-
476 ANEMIA DURING TREATMENT WITH PEGINTERFERON ALFA-2B/ RIBAVIRIN WITH OR WITHOUT BOCEPREVIR IS ASSOCIATED WITH HIGHER SVR RATES: ANALYSIS OF PREVIOUSLY UNTREATED AND PREVIOUS-TREATMENT-FAILURE PATIENTSSulkowski, M. S. / Poordad, F. / Manns, M. P. / Bronowicki, J. P. / Reddy, K. R. / Harrison, S. A. / Afdhal, N. H. / Boparai, N. / Sniukiene, V. / Burroughs, M. et al. | 2011
- S195
-
478 INFECTIONS DURING PEGINTERFERON (PEGIFN)/RIBAVIRIN (RBV) THERAPY ARE ASSOCIATED WITH THE MAGNITUDE OF DECLINE IN THE LYMPHOCYTE COUNT: RESULTS OF THE IDEAL STUDYMelia, M. / Brau, N. / Poordad, F. / Lawitz, E. J. / Shiffman, M. / McHutchison, J. / Muir, A. / Galler, G. / McCone, J. / Nyberg, L. et al. | 2011
- S197
-
482 IN VITRO COMBINATION THERAPY WITH TEGOBUVIR (GS-9190) IS HIGHLY EFFICIENT IN CURING CELLS FROM HCV REPLICON AND IN DELAYING/PREVENTING THE DEVELOPMENT OF ANTIVIRAL RESISTANCEVliegen, I. / Delang, L. / Paeshuyse, J. / Shih, I. H. / Purstinger, G. / Bondy, S. / Lee, W. A. / Zhong, W. / Neyts, J. et al. | 2011
- S198
-
484 PREDICTORS OF SUSTAINED VIROLOGIC RESPONSE AMONG GENOTYPE 1 PREVIOUS NON-RESPONDERS AND RELAPSERS TO PEGINTERFERON/RIBAVIRIN WHEN RE-TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRINZeuzem, S. / Vierling, J. M. / Esteban, R. / Gibas, A. L. / Pol, S. / Boparai, N. / Burroughs, M. / Brass, C. A. / Albrecht, J. K. / Poordad, F. et al. | 2011
- S201
-
492 GAHS TAHP: THE GLASGOW ALCOHOLIC HEPATITIS SCORE IN THE TREATMENT OF ALCOHOLIC HEPATITIS IN PRACTICELafferty, H. / Watson, E. / Hamid, R. / Morris, J. / Winter, J. / Stanley, A. / Forrest, E. et al. | 2011
- S202
-
495 THE IMPACT OF DIABETES MELLITUS ON THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA AMONG PATIENTS WITH ALCOHOLIC LIVER CIRRHOSIS AND DIABETES MELLITUSKim, H. C. / Cho, E. Y. / Lee, J. Y. / Kim, T. H. et al. | 2011
- S203
-
498 DRUG INDUCED LIVER INJURY RESULTING IN ACUTE LIVER FAILURE: AN ASIAN EXPERIENCELim, K. / Dan, Y. Y. / Gowans, M. / Mo, A. / Lee, Y. M. / Lim, S. G. et al. | 2011
- S204
-
501 PROGNOSTIC SCORES ARE EFFICIENT IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS TREATED WITH CORTICOSTEROIDS: COMPARISON OF AVAILABLE MODELSLouvet, A. / Artru, F. / Diaz, E. / Wartel, F. / Castel, H. / Dharancy, S. / Lassailly, G. / Canva-Delcambre, V. / Deltenre, P. / Mathurin, P. et al. | 2011
- S207
-
508 ENHANCED SPERMINE/SPERMIDINE-N1-ACETYLTRANSFERASE EXPRESSION CONTRIBUTES TO CELLULAR DAMAGE IN CCL4 INDUCED HEPATOTOXIC INJURYZahedi, K. / Barone, S. / Steinbergs, N. / Casero, R. A. / Soleimani, M. et al. | 2011
- S210
-
513 MELATONIN ADMINISTRATION PREVENTS INFLAMMATION PROCESSES AND REDUCES LIVER INJURY IN ZUCKER RATS AFTER ISCHEMIA/REPERFUSIONKireev, R. / Samuel, B. / Sara, C. / Elena, V. / Moreno, E. / Tresguerres, J. A. et al. | 2011
- S211
-
515 LENIWIRAL `GENE ONTOLOGY' (LEGO) VECTORS ENABLE HIGHLY EFFICIENT EX VIVO TRANSDUCTION OF HEPATOCYTES SUITABLE FOR CELL TRANSPLANTATIONWarlich, M. / Weber, K. / Thomaschewski, M. / Lutgehetmann, M. / Volz, T. / Pollok, J. M. / Gersting, S. / Borsch, J. / Santer, R. / Ullrich, K. et al. | 2011
- S212
-
518 UNFAVORABLE IMPACT OF HCV INFECTION ON TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH COMPENSATED LIVER DISEASE: INSIGHTS FROM THE LIVER MATCH COHORT STUDYAngelico, M. / Marianelli, T. / Cilio, U. / Fagiuoli, S. / Gasbarrini, A. / Gavrila, C. / Romagnoli, R. / Strazzabosco, M. / Nardi, A. et al. | 2011
- S213
-
521 PATIENTS SURVIVING AT LEAST 10 YEARS POST LIVER TRANSPLANTATION: LONG TERM COMPLICATIONSBerenguer, M. / Rubin, A. / Aguilera, V. / Sanchez-Montes, C. / Garcia-Eliz, M. / Castello, B. / Ortiz, C. / Sanjuan, F. / Moya, A. / Montalva, E. et al. | 2011
- S214
-
523 PROTRACTED ANTIVIRAL TREATMENT BEYOND CONVENTIONAL TIME LIMITS IMPROVES SURVIVAL IN NON-RESPONDERS TO INTERFERON+RIBAVIRIN ADMINISTERED FOR HCV RECURRENCE AFTER LIVER TRANSPLANTATIONBertuzzo, V. / Vigano, R. / Donato, M. F. / Marino, M. / Rendina, M. / Fornasiere, E. / Pasulo, L. / Burra, P. / Miglioresi, L. / Giannelli, V. et al. | 2011
- S216
-
528 IMPROVEMENT OF SURVIVAL IN 24 MONTHS OF PATIENTS IN LIVER TRANSPLANT LIST AFTER THE INTRODUCTION OF MELD IN BRAZILCastro, R. S. / Seva-Pereira, T. / Dei Santi, D. B. / Machado, H. / Almeida, J. R. / Boin, I. F. / Soares, E. C. et al. | 2011
- S217
-
531 EARLY IDENTIFICATION OF TWO PATTERNS OF HEPATITIS C RECURRENCE (RAPID AND SLOW PROGRESSORS) AFTER LIVER TRANSPLANTATION: A PROSPECTIVE LONG-TERM FOLLOW-UP STUDYCrespo, G. / Carrion, J. A. / Lens, S. / Garcia-Retortillo, M. / Miquel, R. / Garcia-Pagan, J. C. / Fondevila, C. / Garcia-Valdecasas, J. C. / Bosch, J. / Bruguera, M. et al. | 2011
- S218
-
534 LOW CIRCULATING CD4CD25HIGHFOXP3+ T CELLS IN LIVER TRANSPLANT PATIENTS WHO EXPERIENCE ACUTE CELLULAR REJECTIONFan, H. / He, Q. / Li, Q. J. / Qi, Z. H. et al. | 2011
- S219
-
537 A SUSTAINED VIRAL RESPONSE DRAMATICALLY IMPROVES SURVIVAL IN PATIENTS WITH HEPATITIS C INFECTION AFTER LIVER TRANSPLANTClark, V. C. / Dhanasekaran, R. / Soldevila-Pico, C. / Morelli, G. / Cabrera, R. / Suman, A. / Nelson, D. R. / Firpi, R. J. et al. | 2011
- S221
-
542 LIVER DISEASE IN ALCOHOLICS POST LIVER TRANSPLANTATIONGraziadei, I. W. / Zoller, H. / Sperner-Unterweger, B. / Pratschke, J. / Vogel, W. et al. | 2011
- S222
-
545 MTOR-INHIBITORS REDUCE THE INCIDENCE OF CYTOMEGALOVIRUS INFECTION AFTER LIVER TRANSPLANTATIONHartl, J. / Scherer, M. N. / Loss, M. / Farkas, S. / Schnitzbauer, A. / Baier, L. / Schlitt, H. J. / Salzberger, B. / Kirchner, G. I. et al. | 2011
- S223
-
548 POSITIVE IMPACT OF AN INFORMATION CAMPAIGN IN ACCESS TO LIVER TRANSPLANTATION IN A FRENCH REGIONHeurgue-Berlot, A. / Bernard-Chabert, B. / Reiter-Chenel, V. / Marquestaut, O. / Thiefin, G. et al. | 2011
- S225
-
553 LIVER TRANSPLANTATION FOR HEPATITIS B VIRUS BACKGROUND HEPATOCELLULAR CARCINOMA: A PROSPECTIVE STUDY COMPARING MILAN AND HANGZHOU CRITERIA AT A SINGLE TRANSPLANTATION CENTER IN CHINAGao, T. / Li, Q. / Wang, S. / Feng, Y. / Chi, J. / Chen, S. / Qiu, Y. / Xia, Q. / Li, H. et al. | 2011
- S226
-
555 TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) AFTER LIVER TRANSPLANTATION (LT): VASCULAR COMPLICATIONS CONSTITUTE A GOOD INDICATIONSenzolo, M. / Magini, G. / Burroughs, A. / Agazzi, R. / Colledan, M. / Zanus, G. / Gaffuri, G. / Fagiuoli, S. et al. | 2011
- S227
-
558 STATINS BEFORE AND AFTER LIVER TRANSPLANTATION - A RANDOMISED CONTROL TRIAL WITH 5-YEAR FOLLOW-UPMela, M. / Gelson, W. / Unitt, E. / Alexander, G. et al. | 2011
- S228
-
560 DROP-OUT ON THE LIVER TRANSPLANTATION WAITING LIST IN A MELD-BASED ALLOCATION MODEL. MULTICENTRIC STUDY OF CAUSES AND RISK FACTORSPleguezuelo, M. / Benitez, J. M. / Poyato, A. / Montero Alvarez, J. L. / Lopez-Cillero, P. / Gomez-Bravo, J. M. / Pascasio, J. M. / Santoyo, J. / Rodrigo, J. M. / Ferron, J. A. et al. | 2011
- S230
-
565 SAFE AND EFFECTIVE USE OF HYPERBARIC OXYGEN THERAPY FOR HEPATIC ARTERY THROMBOSIS AFTER LIVER TRANSPLANTATIONRicchiuti, A. / Brunati, A. / Maffi, L. / Righi, D. / Maione, F. / Reggio, D. / Salizzoni, M. et al. | 2011
- S231
-
568 EXPRESSION OF gH2AX (A DNA DAMAGE MARKER) IN PRE-TRANSPLANT CIRCULATING LYMPHOCYTES PREDICTS DEATH FOLLOWING LIVER TRANSPLANTATIONShankar, A. / Hoare, M. / Gelson, W. / Alexander, G. et al. | 2011
- S232
-
571 TRANSPLANTATION OF THE LIVER FROM A HBCAB POSITIVE DONOR INTO A HCV-RNA POSITIVE RECIPIENT ADVERSELY AFFECTS GRAFT SURVIVAL AND WORSENS THE COURSE OF HCV-RECURRENCETandoi, F. / Romagnoli, R. / Catalano, G. / Gonella, F. / Bosso, M. C. / Bertolotti, G. / Saffioti, M. C. / Salizzoni, M. et al. | 2011
- S234
-
576 POST-TRANSPLANT ENCEPHALOPATHYTryc, A. B. / Goldbecker, A. / Afshar, K. / Hamidi Shahrezaei, G. / Rumke, S. / Barg-Hock, H. / Strassburg, C. / Weissenborn, K. et al. | 2011
- S236
-
581 THE NEW CONCEPT OF "GRAFT SURVIVAL BENEFIT' IN LIVER TRANSPLANTATIONVitale, A. / Morales, R. R. / Burra, P. / Zanus, G. / Cilio, U. et al. | 2011
- S237
-
584 RECIPIENT CYP2D64 POOR METABOLIZER STATUS ASSOCIATES WITH EARLY FIBROSIS DEVELOPMENT AFTER LIVER TRANSPLANTATIONZimmermann, T. / Hoppe-Lotichius, M. / Korner, A. / Lautem, A. / Heise, M. / Galle, P. R. / Otto, G. / Schuchmann, M. et al. | 2011
- S238
-
586 THE NATURAL COURSE OF HEPATIC FIBROSIS MICE MODEL DURING PREGNANCYAmer, J. / Grifat, R. / Abu-Tair, L. / Doron, S. / Safadi, R. et al. | 2011
- S239
-
589 PROGNOSTIC IMPLICATION OF AUTONOMIC DYSFUNCTION IN NON CIRRHOTIC PORTAL HYPERTENSION: DO WE NEED TO INTERVENE?Behl, N. / Ajmera, S. / Gupta, R. C. / Nijhawan, S. / Nepalia, S. et al. | 2011
- S240
-
592 POSITIVE CARDIAC INOTROPIC EFFECT OF ALBUMIN INFUSION IN RATS WITH CIRRHOSIS AND ASCITES: MOLECULAR MECHANISMSBortoluzzi, A. / Sticca, A. / Segato, G. / Ceolotto, G. / Bova, S. / Gatta, A. / Angeli, P. et al. | 2011
- S241
-
595 BENEFICIAL EFFECT OF N-ACETYL-CYSTEINE ON HEPATIC ENCEPHALOPATHY: "IN VIVO" AND "IN VITRO" STUDYDibenedetto, A. / Donnini, D. / Domenis, L. / De Silvestri, D. / Cappello, D. / Carnelutti, A. / Veriello, L. / Pauletto, G. / Sechi, L. / Soardo, G. et al. | 2011
- S242
-
598 HEMODYNAMIC AND RENAL EFFECTS OF AN ORAL PRODRUG OF NOREPINEPHRINE IN PORTAL HYPERTENSIVE RATSColl, M. / Raurell, I. / Ezkurdia Garmendia, N. / Cuenca, S. / Martell, M. / Genesca, J. et al. | 2011
- S244
-
602 PNPLA3 RS734809 C/G POLYMORPHISM IN LIVER CIRRHOSIS: RELATIONSHIP WITH THE ETIOLOGY OF LIVER DISEASE AND HCC OCCURRENCEFornasiere, E. / Cmet, S. / Cussigh, A. / Bitetto, D. / Furnolo, E. / Bignulin, S. / Fontanini, E. / Bignulin, E. / Falleti, E. / Fabris, C. et al. | 2011
- S245
-
605 DIASTOLIC DYSFUNCTION DEFINED BY E/A RATIO <1 ON 2-D ECHO IS AN INDEPENDENT PREDICTOR OF LIVER TRANSPLANTATION OR DEATH IN PATIENTS WITH CIRRHOSISHolt, E. W. / Woo, G. / Trilesskaya, M. / Haeusslein, E. A. / Shaw, R. E. / Frederick, R. T. et al. | 2011
- S246
-
608 H2O2 RAPIDLY ACTIVATES THE SYSTEMIC IRON HORMONE HEPCIDIN INDEPENDENT OF THE IL-6/BMP6 NETWORKMillonig, G. / Ganzleben, I. / Casanovas, G. / Peccerella, T. / Muckenthaler, M. / Seitz, H. K. / Mueller, S. et al. | 2011
- S247
-
610 FUNCTIONAL STUDY OF THE INTESTINAL BARRIER IN PATIENTS WITH CIRRHOSIS AND PORTAL HYPERTENSIONNadal, E. / Buda, A. / Pizzuti, D. / Nai, L. / Burra, P. / Senzolo, M. et al. | 2011
- S248
-
613 NEBIVOLOL DETERIORATES PORTAL HEMODYNAMICS IN CIRRHOTIC RATS BY INCREASING SPLANCHNIC BLOOD FLOWReiberger, T. / Payer, B. A. / Angermayr, B. / Fuhrmann, V. / Schwabl, P. / Jager, B. / Hummel, T. / Horvatits, T. / Mitterhauser, M. / Peck-Radosavljevic, M. et al. | 2011
- S249
-
615 NA-K-CL COTRANSPORTER IS IMPLICATED IN THE PATHOGENESIS OF BRAIN EDEMA IN RATS WITH BILE DUCT LIGATIONHuynh, J. / Bosoi, C. R. / Parent-Robitaille, C. / Tremblay, M. / Rose, C. F. et al. | 2011
- S251
-
621 INTERLEUKIN-8 (IL-8) AND IL-8 RELATED PATHWAYS ARE ACTIVATED IN CHRONIC LIVER DISEASE DEPENDENT ON DISEASE SEVERITY AND ETIOLOGY OF CIRRHOSISZimmermann, H. / Seidler, S. / Gassler, N. / Trautwein, C. / Tacke, F. et al. | 2011
- S253
-
625 A SYSTEMATIC REVIEW AND META-ANALYSIS OF TRANSARTERIAL RADIOEMBOLIZATION (TARE) FOR HEPATOCELLULAR CARCINOMA (HCC)Higgins, L. / Rose, S. / Lorenzetti, D. / Sutherland, L. / Burak, K. W. et al. | 2011
- S254
-
628 RADIOFREQUENCY ABLATION VERSUS LASER ABLATION FOR THE TREATMENT OF SMALL HEPATOCELLULAR CARCINOMA: A RANDOMIZED CONTROLLED TRIALPi Costanzo, G. G. / Tortora, R. / DAdamo, G. / Galeota Lanza, A. / Carannante, N. / Lampasi, F. / De Luca, M. / Tartaglione, M. T. / Pacella, C. M. et al. | 2011
- S256
-
633 TUMOUR SIZE OF HCC AND ITS RELATIONSHIP TO OUTCOME AFTER LIVER TRANSPLANTATIONGermani, G. / Garcovich, M. / Gurusamy, K. / Toso, C. / Fede, G. / Tsochatzis, E. / Burroughs, A. K. et al. | 2011
- S257
-
636 OBSERVATION OF BUBBLES AND DETECTION OF HEPATOCYTES IN THE PORTAL VEIN DURING RADIOFREOJUENCY ABLATIONKawamoto, C. / Manaka, K. I. / Yamauchi, A. / Kaneko, K. / Miyamoto, R. / Shimizu, H. / Mizuno, K. et al. | 2011
- S258
-
639 SINGLE NUCLEOTIDE POLYMORPHISM ASSOCIATED WITH TUMOR RESPONSE TO THE COMBINED THERAPY WITH TRANSARTERIAL CHEMOEMBOLIZATION AND SORAFENIB IN PATIENTS WITH HEPATOCELLULAR CARCINOMALee, J. H. / Chung, Y. H. / Kim, J. A. / Shin, E. S. / Lee, D. / Shim, J. H. / Lee, H. C. / Yoon, J. H. / Kim, B. I. / Bae, S. H. et al. | 2011
- S259
-
642 BARCELONA-CLINIC-LIVER-CANCER (BCLC) STAGING AND ACTUAL THERAPY RECEIVED IN HIV-INFECTED PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC), COMPARING DIAGNOSIS PRE-2006 AND 2006 AND LATERMerchante, N. / Kikuchi, L. / Marks, K. / Rivero, A. / Palys, E. / Mata, R. / Wigg, A. / Vachon, M. L. / Silva, M. / Marquez-Molero, M. et al. | 2011
- S260
-
645 SERUM CARBONIC ANHYDRASE 9 (CA) IS A VALUABLE BIOMARKER (BM) TO PROFILE PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) TREATED WITH SORAFENIB AND PREDICT THEIR OUTCOMEReig, M. E. / Boix, L. / Forner, A. / Rimola, J. / Rodriguez de Lope, C. / Lopez-Oliva, J. M. / Tremosini, S. / Llarch, N. / Llovet, J. M. / Ayuso, C. et al. | 2011
- S262
-
650 SURVIVAL AND TOLERABILITY FOLLOWING Y-RESIN MICROSPHERE RADIOEMBOLISATION IN PATIENTS WITH UNRESECTABLE BCLC STAGE C HEPATOCELLULAR CARCINOMA (HCC)Sangro, B. / Ettorre, G. M. / Cianni, R. C. / Gasparini, D. / Golfieri, R. / Ezzidin, S. / Kolligs, F. / Izzo, F. et al. | 2011
- S264
-
655 CLINICAL FEATURES AND RISK FACTORS OF EXTRAHEPATIC SEEDING AFTER PERCUTANEOUS RADIOFREOJUENCY ABLATION FOR HEPATOCELLULAR CARCINOMAShirai, K. / Tamai, H. / Shingaki, N. / Mori, Y. / Moribata, K. / Enomoto, S. / Deguchi, H. / Ueda, K. / Maekita, T. / Inoue, I. et al. | 2011
- S265
-
658 HEPATIC RESECTION CAN PROVIDE LONG-TERM SURVIVAL OF PATIENTS IN BARCELONA CLINICAL LIVER CANCER STAGE B OR C HEPATOCELLULAR CARCINOMASu, C. W. / Chau, G. Y. / Hsia, C. Y. / Wu, J. C. / Huo, T. I. / Huang, Y. H. / Lin, H. C. / Lui, W. Y. / Lee, S. D. et al. | 2011
- S266
-
661 BIOLOGICAL DOWNSTAGING OF INTERMEDIATE HEPATOCELLULAR CARCINOMA IN PATIENTS TREATED WITH SORAFENIB: FINAL REPORT OF A PROSPECTIVE STUDYVitale, A. / Morales, R. R. / Cilio, U. et al. | 2011
- S267
-
663 PREDICTIVENESS OF WASH-OUT TIME INTENSITY CURVE ON HEPATOCELLULAR CARCINOMA RECURRENCEWitjes, C. D. / Willemssen, F. E. / Verheij, J. / van der Veer, S. J. / Hansen, B. E. / Verhoef, C. / de Man, R. A. / Ijzermans, J. N. et al. | 2011
- S269
-
668 STAT1 AND STAT2 TRANSCRIPTION FACTORS EXPRESSION IS UPREGULATED IN HBV REPLICATING CELLS BY DISTINCT MECHANISMSBelloni, L. B. / Guerrieri, F. / Scisciani, C. / Levrero, M. et al. | 2011
- S270
-
671 SERPINB3 INCREASES RESISTANCE TO CISPLATIN- OR DOXORUBICIN-INDUCED CELL DEATH IN HEPATOMA CELLS THROUGH DEREGULATION OF PERMEABILITY TRANSITION PORECiscato, F. / Sciacovelli, M. / Ruvoletto, M. / Cmarta, S. / Bernardi, P. / Rasola, A. / Gatta, A. / Pontisso, P. et al. | 2011
- S271
-
674 HEPATOCYTE-SPECIFIC DELETION OF CFLIP ENHANCES LIVER INJURY FROM STREPTOZOTOCIN-INDUCED HYPERGLYCEMIA INVOLVING ACTIVATION OF JNKSchattenberg, J. M. / Kohl, T. / Nagel, M. / Wagner, I. / Kreft, A. / He, Y. W. / Galle, P. R. / Schuchmann, M. et al. | 2011
- S272
-
677 TRANSFORMING GROWTH FACTOR-b/P38 MAP KINASE SIGNALING CONTRIBUTES TO SORAFENIB RESISTANCE IN HEPATOMAMatsuda, Y. / Wakai, T. / Shirai, Y. / Yano, M. / Ohkoshi, S. / Aoyagi, Y. / Fujimaki, S. / Sanpei, A. / Hirano, S. et al. | 2011
- S273
-
680 NVP BEZ235-AN ALONE OR IN COMBINATION WITH CHEMOTHERAPY EFFECTIVELY INHIBITS HEPATOCELLULAR CARCINOMA GROWTHPothiraju, P. / Manns, M. P. / Vogel, A. et al. | 2011
- S274
-
683 RECOMBINANT ADENOVIRUS IL-24-BAX PROMOTES APOPTOSIS OF HEPATOCELLULAR CARCINOMA CELLS IN VITRO AND IN VIVOShi, L. et al. | 2011
- S276
-
688 ENDOPLASMIC RETICULUM FOLDING AND QUALITY CONTROL IN CHOLANGIOCARCINOMA: A ROLE FOR ANTERIOR GRADIENT 2Lepreux, S. / Bioulac-Sage, P. / Mulot, A. / Balabaud, C. / Delom, F. / Higa-Nishiyama, A. / Bouchecareilh, M. / Chevet, E. et al. | 2011
- S277
-
691 CHARACTERIZATION OF THE PURINOME ON THE BILIARY EPITHELIAGodoy, V. / Banales, J. M. / Medina, J. F. / Pastor-Anglada, M. et al. | 2011
- S278
-
693 THE CELL SOURCES AND DIFFERENTIATION OF INTRAHEPATIC BILE DUCTS DURING HUMAN LIVER DEVELOPMENTGumerova, A. / Kiassov, A. / Titova, M. / Abdulkhakov, S. / Kaligin, M. / Mavlikeev, M. et al. | 2011
- S280
-
699 SUCCESSFUL ISOLATION, CULTURING AND DIFFERENTIATION IN VITRO AND IN VIVO OF MULTIPOTENT STEM CELLS (MPS) FROM HUMAN FETAL BILIARY TREESemeraro, R. / Torrice, A. / Napoli, C. / Cardinale, V. / Carpino, G. / Gentile, R. / Gatto, M. / Di Tondo, U. / Brunelli, R. / Anceschi, M. M. et al. | 2011
- S283
-
706 MUTATION RTA181T/SW172 IS ASSOCIATED WITH LOWER HBSAG LEVELS THAN OTHER MUTATIONS IN HBV POLYMERASE CODON 181 AND OVERLAPPING SURFACE CODON 172 -IMPLICATIONS FOR VACCINATION?Bruce, M. / Horner, M. / Shang, D. / Fletcher, I. / Suddle, A. / Harrison, P. M. / Agarwal, K. / Carey, I. et al. | 2011
- S284
-
708 OVERLAPPING STRUCTURE OF HBV GENOME AND IMMUNE SELECTING PRESSURE ARE THE MAIN DRIVING FORCES FOR HBV EVOLUTIONCento, V. / Mirabelli, C. / Salpini, R. / Han, Y. / Mercurio, F. / Dimonte, S. / Beggel, B. / Wittkop, L. / Fraune, M. / Gori, C. et al. | 2011
- S285
-
711 EFFICACY OF PEGYLATED INTERFERON ALPHA-2B IN A ROMANIAN COHORT WITH CHRONIC HEPATITIS DELTAGheorghe, L. / Iacob, S. / Simionov, I. / Vadan, R. / Constantinescu, I. / Sporea, I. / Grigorescu, M. et al. | 2011
- S286
-
714 HBSAG LEVELS DURING THE FIRST 24 WEEKS OF PEGINTERFERON ALFA-2A [40KD] (PEGASYS) TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B: THE PERSEAS COHORTGoulis, I. / Akriviadis, E. / Karatapanis, S. / Deutsch, M. / Dalekos, G. / Raptopoulou-Gigi, M. / Drakoulis, C. / Bakalos, G. / Papatheodoridis, G. et al. | 2011
- S289
-
722 STUDY OF INFLUENCE FACTORS ON HBV RELAPSE AFTER NAS WITHDRAWAL IN THE CHB PATIENTS WHO MET NAS CESSATION CRITERIAJiang, N. J. / Liang, X. Y. / Su, H. M. / Liu, H. Z. / Ge, E. S. / Hu, G. J. / Guo, W. W. / Jiang, C. Z. / Zhu, Q. M. / Huang, H. X. et al. | 2011
- S291
-
727 LONG-TERM EFFICACY AND IMPACT ON HEPATOCELLULAR CARCINOMA DEVELOPMENT OF NUCLEOSIDE ANALOGUE TREATMENT WITH LAMIVUDINE AND ENTECAVIR FOR CHRONIC HEPATITIS B AND CIRRHOSISKobashi, H. / Miyake, Y. / Ikeda, F. / Yasunaka, T. / Nishino, K. / Moriya, A. / Kubota, J. I. / Nakamura, S. / Takaki, A. / Nouso, K. et al. | 2011
- S293
-
731 EFFECTIVENESS AND SAFETY OF TENOFOVIR DISOPROXIL FUMARATE IN FIELD PRACTICE: A MULTICENTER EUROPEAN COHORT STUDY OF 302 NUC-NAIVE PATIENTS WITH CHRONIC HEPATITIS BLampertico, P. / Soffredini, R. / Vigano, M. / Yurdaydin, C. / Idilman, R. / Papatheodoridis, G. V. / Margariti, K. / Buti, M. / Esteban, R. / Zaltron, S. et al. | 2011
- S294
-
733 ANTIVIRAL-THERAPY IN PREGNANCY FOR PREVENTION OF HBV TRANSMISSION: SEVERE POST PARTUM HEPATIC FLARES ARE COMMON AND USUALLY SELF LIMITINGLevy, M. / Glass, A. / Manoharan, S. / Paven, G. / Ng, W. / Wiseman, E. / Locarnini, S. / Ayres, A. et al. | 2011
- S295
-
736 LAMIVUDINE IN LATE PREGNANCY FOR PREVENTION OF HBV TRANSMISSION: EFFECTIVENESS AND DETECTION OF ANTIVIRAL RESISTANCEAyres, A. / Yuen, L. / Manoharan, S. / Glass, A. / Nguyen, R. / Ng, W. / Maley, M. / Paven, G. / Levy, M. T. / Locarnini, S. et al. | 2011
- S296
-
739 EFFECTS OF TENOFOVIR DISOPROXIL FUMARATE ON RENAL FUNCTION IN CHRONIC HBV PATIENTS IN THREE GLOBAL RANDOMIZED STUDIESMarcellin, P. / Heathcote, E. J. / Berg, T. / Anderson, J. / Mondou, E. / Coombs, D. / Ebrahimi, R. / Reddy, S. / Lopatin, U. / McNally, J. et al. | 2011
- S297
-
741 GENOTYPE-SPECIFIC MUTATIONS IN THE RT REGION OF HBV POLYMERASE POTENTIALLY ASSOCIATED TO DEVELOPMENT AND EVOLUTION OF RESISTANCE TO ORAL ANTIVIRAL THERAPYMirandola, S. / Campagnolo, D. / Bortoletto, G. / Marcolongo, M. / Franceschini, L. / Alberti, A. et al. | 2011
- S298
-
743 SHORT-TERM EFFECTS AND LONG-TERM FOLLOW-UP OF LIVER FAILURE PATIENTS CAUSED BY HEPATITIS B AFTER SINGLE TRANSPLANTATION WITH AUTOLOGOUS BONE MARROW MESENCHYMAL STEM CELLSPeng, L. / Liu, J. / Zheng, B. Y. / Gao, Z. L. et al. | 2011
- S299
-
745 STOPPING LONG-TERM NUCLEOS(T)IDE ANALOGUE THERAPY BEFORE HBSAG LOSS OR SERO-CONVERSION IN HBEAG NEGATIVE CHB PATIENTS: EXPERIENCE FROM FOUR REFERRAL CENTERS IN GERMANYPetersen, J. / Buggisch, P. / Stoehr, A. / Sabranski, M. / Hinrichsen, H. / Mauss, S. / Port, K. / Kirschner, J. / Manns, M. P. / Wedemeyer, H. et al. | 2011
- S301
-
750 A COMPARISON OF TWO ASSAYS FOR QUANTIFICATION OF HEPATITIS B SURFACE ANTIGEN IN SERUM OF PATIENTS WITH CHRONIC HEPATITIS BSonneveld, M. J. / Rijckborst, V. / Boucher, C. A. / Zwang, L. / Beersma, M. F. / Hansen, B. E. / Janssen, H. L. et al. | 2011
- S302
-
753 NUCLEOS(T)IDE ANALOGUES CAN BE SAFELY DISCONTINUED IN CHRONIC HEPATITIS B PATIENTS ACHIEVING HBSAG SEROCLEARANCEVezali, E. / Lampertico, P. / Invernizzi, F. / Iavarone, M. / Vigano, M. / Facchetti, F. / Lunghi, G. / Colombo, M. et al. | 2011
- S303
-
756 RESULTS OF THE PEG-IFN TREATMENT IN THE HBEAG POSITIVE AND NEGATIVE CHRONIC HEPATITIS B PATIENTS: POST-TREATMENT ONE YEAR RESULTS OF THREE TURKISH CENTERSYamazhan, T. / Kurtaran, B. / Pullukcu, H. / Yuksel, E. / Ozkaya, D. / Tasbakan, M. I. / Sipahi, O. R. / Durusoy, R. / Aksu, H. S. et al. | 2011
- S304
-
758 A STUDY OF ANTIVIRAL THERAPY WITH LAMIVUDINE BEGINNING IN THE SECOND OR LAST TRIMESTER OF PREGNANCY IN PREVENTING VERTICAL TRANSMISSION OF HEPATITIS B VIRUSYu, M. / Jiang, Q. / Ji, Y. / Jiang, H. / Wu, K. / Ju, L. et al. | 2011
- S305
-
759 DEVELOPMENT AND CREATION OF SENSITIVE PROGNOSTIC SCORING SYSTEM THAT IS APPLICABLE FOR THE SEVERITY OF ACUTE-ON-CHRONIC LIVER FAILURE IN HEPATITIS BZheng, Y. B. / Xie, D. Y. / Lin, C. S. / Lei, Z. Y. / Peng, L. / Lin, B. L. / Ke, W. M. / Chong, Y. T. / Gao, Z. L. et al. | 2011
- S306
-
761 IN VIVO INTRACELLULAR INJECTION NEEDLE (IVIN) TECHNOLOGY: A NEW NEEDLE FOR IMPROVED CELLULAR UPTAKE OF DNA IN A LIVE ANIMALAhlen, G. / Frelin, L. / Sallberg, M. et al. | 2011
- S307
-
764 IN VITRO PROFILING OF GSK2336805, A POTENT AND SELECTIVE INHIBITOR OF HCV NS5ABechtel, J. / Crosby, R. / Wang, A. / Woldu, E. / Van Horn, S. / Horton, J. / Creech, K. / Caballo, L. H. / Voitenleitner, C. / Vamathevan, J. et al. | 2011
- S309
-
769 USP18 STIMULATES HCV PRODUCTION: UPREGULATION OF THE SURFACE ENTRY RECEPTOR CD81 IN VITROChen, L. / Sun, J. / Lin, L. T. / Ma, M. X. / Heathcote, J. / Richardson, C. et al. | 2011
- S310
-
772 SINGLE NUCLEOTIDE POLYMORPHISMS IN HUMAN CYCLOPHILIN A AND THEIR INFLUENCE ON HCVRNA REPLICATION IN VITROvon Hahn, T. / Karavul, B. / Steinmann, E. / Potthoff, A. / Strassburg, C. P. / Wedemeyer, H. / Manns, M. P. / Pietschmann, T. / Ciesek, S. et al. | 2011
- S311
-
775 HCV REPLICATION REGULATES GENES IMPLICATED IN MRNA TRANSLATION AT THE POST-TRANSCRIPTIONAL LEVELColman, H. / Seoul, C. / Hernandez, C. / Pierredon, S. / Bihoudee, A. / Houlgatte, R. / Vagner, S. / Rosenberg, A. / Feray, C. et al. | 2011
- S312
-
777 ROLE OF RAPAMYCIN AS MTOR INHIBITOR IN VITRO AND ITS USE IN THE TREATMENT OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATIONDel Campo, J. A. / Bonnel, A. / Cuaresma, M. / Shaked, O. / Garcia-Valdecasas, M. / Rajender Reddy, K. / Romero Gomez, M. et al. | 2011
- S314
-
782 HEPATIC MIRNA SIGNATURE PREDICTING SUSTAINED VIROLOGICAL RESPONSE IN CHRONIC HEPATITIS CEstrabaud, E. / Bieche, I. / Lapalus, M. / De Muynck, S. / Lada, O. / Martinot-Peignoux, M. / Duces, A. / Valla, D. / Bedossa, P. / Marcellin, P. et al. | 2011
- S315
-
785 OXIDATIVE DNA DAMAGE IN PATIENTS WITH CHRONIC HCV-RELATED LIVER DISEASES: PROTECTIVE EFFECT OF COFFEE CONSUMPTIONCardin, R. / Piciocchi, M. / Martines, D. / Scribano, L. / Floreani, A. / Petracco, M. / Farinati, F. et al. | 2011
- S318
-
793 HEPATITIS C VIRUS INDUCES ULTRASTRUCTURAL MODIFICATIONS IN DIFFERENTIATED HUH7.5 CELLSJammart, B. / Pecheur, E. I. / Roingeard, P. / Zoulim, F. / Durantel, D. et al. | 2011
- S319
-
796 MIR-122 AND MIR-221 EXPRESSION IN STEATOTIC AND NON-STEATOTIC HEPATITIS C LIVER BIOPSIESLendvai, G. / Jarmay, K. / Kiss, A. / Kovalszky, I. / Schaff, Z. et al. | 2011
- S320
-
799 KINETICS OF HEPATIC AND CIRCULATING MICRORNA-122 DURING EXPERIMENTAL ACUTE HCV INFECTIONKrawczynski, K. / Choi, Y. / Odenthal, M. / Ruhrlander, M. / Muller, M. / Dienes, H. P. et al. | 2011
- S321
-
801 A PRIMARY CULTURE ADULT HUMAN LIVER SLICES: AN EX VIVO MODEL OF HCV DE NOVO INFECTIONLagaye, S. / Shen, H. / Gaston, J. / Bourdoncle, P. / Hannoun, L. / Massault, P. P. / Vallet-Pichard, A. / Mallet, V. / Pol, S. et al. | 2011
- S323
-
806 TRIPHASIC VIRAL LOAD KINETICS OF HEPATITIS C VIRUS DURING ANTIVIRAL THERAPY POST-TRANSPLANTATION: EFFECT OF THE TYPE OF PEGYLATED-IFN AND BASELINE IMMUNOSUPPRESSIONOrtiz, C. / Lopez-Labrador, F. X. / Canada, R. / Abellan, J. J. / Risalde, B. / Rubin, A. / Aguilera, V. / Prieto, M. / Berenguer, M. et al. | 2011
- S324
-
809 DYSREGULATION OF MICRO-RNA EXPRESSION IN SPLENIC MARGINAL ZONE LYMPHOMA IN PATIENTS WITH AND WITHOUT CHRONIC HEPATITIS C VIRUS INFECTIONPeveling-Oberhag, J. / Crisman, G. / Schmidt, A. / Doring, C. / Lucioni, M. / Arcaini, L. / Hartmann, S. / Piiper, A. / Hofmann, W. P. / Paulli, M. et al. | 2011
- S325
-
812 METABOLOMIC PROFILE OF HCV-INFECTED HEPATOCYTESRoe, B. / Kensicki, E. / Mohney, R. / Hall, W. W. et al. | 2011
- S326
-
815 IDENIX NS5A HCV REPLICATION INHIBITORS WITH LOW PICOMOLAR, PAN-GENOTYPIC IN VITRO ANTIVIRAL ACTIVITYDousson, C. B. / Chapron, C. / Standring, D. / Bilello, J. P. / McCarville, J. / La Colla, M. / Seifer, M. / Parsy, C. / Dukhan, D. / Pierra, C. et al. | 2011
- S328
-
820 CD81 EXPRESSION ON LYMPHOCYTE SUBTYPES FOR DISCRIMINATION BETWEEN SUSTAINED VIROLOGIC RESPONSE AND RELAPSE IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEG-INTERFERON-ALFA AND RIBAVIRINWelker, M. / Hofmann, W. P. / Lange, C. / Herrmann, E. / Sarrazin, C. / Zeuzem, S. / Kronenberger, B. et al. | 2011
- S330
-
825 SILYBIN CONJUGATED WITH PHOSPHATIDYLCHOLINE AND VITAMIN E IMPROVES LIVER DAMAGE IN PATIENTS WITH NAFLD: THE RESULTS OF A RANDOMIZED MULTICENTRE DOUBLE-BLIND VS PLACEBO TRIALAndreone, P. / Brise, M. C. / Chiaramonte, M. / Federico, A. / Floreani, A. / Freni, M. A. / Grieco, A. / Lobello, S. / Milani, S. / Okolicsanyi, L. et al. | 2011
- S331
-
828 EFFECT OF THE PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR-g (PPARg) GENE ON NON ALCOHOLIC FATTY LIVER DISEASE IN NORTHERN ASIAN INDIANSBhatt, S. P. / Nigam, P. / Misra, A. / Luthra, K. / Jain, S. K. / Qadar Pasha, M. A. / Vaidya, M. et al. | 2011
- S332
-
831 IACE IN TREATMENT OF ARTERIAL HYPERTENTION IN PATIENTS WITH NON ALCOHOLIC FATTY LIVERDrapkina, O. M. / Ivashkin, V. T. et al. | 2011
- S333
-
834 THE PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE IN THE GENERAL POPULATION DURING THE LAST 2009 TO 2010 YEARS IN JAPANEguchi, Y. / Hyogo, H. / Ono, M. / Mizuta, T. / Fujimoto, K. / Chayama, K. / Saibara, T. et al. | 2011
- S335
-
839 SERUM APOLIPOPROTEIN CIII LEVELS DECLINE AFTER WEIGHT LOSS INDUCED IMPROVEMENT IN HEPATIC STEATOSISVerrijken, A. / Francque, S. / Caron, S. / Mertens, I. / Hubens, G. / Van Marck, E. / Staels, B. / Michielsen, P. / Taskinen, M. R. / Van Gaal, L. et al. | 2011
- S336
-
842 PREDISPOSITION TO DEVELOP DIABETES IN SUBJECTS WITH NAFLD IS RELATED TO INSULIN RESISTANCE RATHER THAN TO DECREASED B-CELL FUNCTIONGastaldelli, A. / Petz, R. / Ricotti, A. / Cersosimo, E. / Cusi, K. / DeFronzo, R. et al. | 2011
- S337
-
845 FATTY LIVER DISEASE RISKS IN PRE-ADOLESCENT CHILDRENHepburn, I. S. / Schade, R. R. / Pollack, N. / Misra, S. / Davis, C. et al. | 2011
- S338
-
848 COMPARISON OF NON-INVASIVE MARKERS OF FIBROSIS IN THE ASIAN NON-ALCOHOLIC FATTY LIVER DISEASES POPULATION WITH LOW PREVALENCE OF ADVANCED FIBROSISKim, D. / Yu, S. J. / Chung, G. E. / Lee, J. H. / Kim, W. / Kim, Y. J. / Yoon, J. H. / Lee, H. S. et al. | 2011
- S339
-
851 GENETIC PREDICTORS OF STEATOSIS AND FIBROSIS IN NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD)Mangia, A. / Mottola, L. / Petruzzellis, D. / Piazzolla, V. / Garrubba, M. / Di Paola, R. / Santoro, R. / Trischitta, V. / Vilella, M. / Fanelli, R. et al. | 2011
- S341
-
856 WAIST CIRCUMFERENCE AND PERIHEPATIC ADIPOSE TISSUE AS PREDICTIVE NON-INVASIVE MARKERS IN NAFLDNeagoe, P. / Ianosi, G. / Amzolini, A. / Popescu, M. / Dinca, M. / Calbureanu, M. / Comanescu, V. / Turculeanu, A. et al. | 2011
- S342
-
859 THREE SINGLE NUCLEOTIDE POLYMORPHISMS HAPLOTYPE OF ANGIOTENSINOGEN GENE ASSOCIATED WITH THE PREVALENCE OF JAPANESE NASHOno, M. / Ochi, T. / Munekage, K. / Ogasawara, M. / Hirose, A. / Nozaki-Fujimura, Y. / Takahashi, M. / Okamoto, N. / Iwasaki, S. / Eguchi, Y. et al. | 2011
- S344
-
864 NAFLD AND THE CHANGING FACE OF HEPATOCELLULAR CANCER (HCC)Das, D. / Chattopadyhay, D. / Patanwala, I. / Islam, T. / Walia, D. / Rose, J. / Jaques, B. / Manas, D. M. / Hudson, M. / Reeves, H. L. et al. | 2011
- S345
-
867 ESTROGEN RECEPTOR EXPRESSION BY PERIPHERAL BLOOD MONONUCLEAR CELLS OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)Takahashi, A. / Katsushima, F. / Monoe, K. / Kanno, Y. / Saito, H. / Abe, K. / Ohira, H. et al. | 2011
- S346
-
869 COFFEE CONSUMPTION INCREASES HEPATIC EXPRESSION OF CYTOCHROME P450S AND SIGNIFICANTLY REDUCES LIVER FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)Tillmann, H. / Suzuki, A. / Pang, H. / Dellinger, A. / Guy, C. D. / Moylan, C. A. / Piercy, D. / Smith, M. / Hauser, M. A. / Diehl, A. M. et al. | 2011
- S347
-
872 ADIPONECTIN IN NONALCOHOLIC FATTY LIVER DISEASE: CORRELATION WITH LIVER DAMAGE AND PNPLA3 GENOTYPEValenti, L. / Rametta, R. / Canavesi, E. / Ruscica, M. / Fracanzani, A. L. / Dongiovanni, P. / Galmozzi, E. / Magni, P. / Fargion, S. et al. | 2011
- S349
-
877 SERUM LEVELS OF OMENTIN, CHEMERIN AND ADIPSIN IN PATIENTS WITH BIOPSY-PROVEN NONALCOHOLIC FATTY LIVER DISEASEYilmaz, Y. / Yonal, O. / Kurt, R. / Alahdab, Y. O. / Eren, F. / Imeryuz, N. / Kalayci, C. / Avsar, E. et al. | 2011
- S350
-
880 SERUM DES-ACYLGHRELIN CONCENTRATION IS ASSOCIATED WITH HISTOLOGIC NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)Estep, M. / Vernon, G. / Wang, L. / Stepanova, M. / Younoszai, A. / Elariny, H. / Goodman, Z. / Chandhoke, V. / Baranova, A. / Younossi, Z. et al. | 2011
- S351
-
883 INCIDENCE AND REGRESSION RATES OF NAFLD IN A SEVEN YEARS FOLLOW UP OF A COHORT FROM THE GENERAL POPULATIONZelber-Sagi, S. / Lotan, R. / Webb, M. / Halpern, Z. / Oren, R. et al. | 2011
- S352
-
885 ALTERNATIVE SPLICING IN RESULTING IN A MITOCHONDRIAL DEFECT AND PROGRESSIVE HEPATIC STEATOSIS IN MICEAbd Al Ahad, N. G. / Kao, H. J. / Yang, C. F. / Huang, C. C. / Lin, W. D. / Tsai, F. J. / Chen, T. H. / Tarn, W. Y. / Wu, J. Y. / Chen, Y. T. et al. | 2011
- S353
-
888 MUTATION ANALYSIS OF NORTH INDIAN PEDIATRIC PATIENTS WITH WILSON DISEASE: 25 DIFFERENT MUTATIONSBalakrishnan, P. / Kabra, M. / Kalra, V. / Arora, N. K. et al. | 2011
- S355
-
893 IRON-DEPENDENT REGULATION OF HEPATIC HEPCIDIN EXPRESSION IN HJV-/- MICEGkouvatsos, K. / Pantopoulos, K. et al. | 2011
- S357
-
898 IDIOPATHIC LIVER FUNCTION TEST ABNORMALITY IN PREGNANCY IS ASSOCIATED WITH IN-VITRO FERTILIZATIONMaor, Y. / Kopylov, U. / Sivan, E. / Avidan, B. et al. | 2011
- S358
-
901 PHENOTYPIC VARIATION AND LONG TERM OUTCOME OF HEPATOBILIARY AND RENAL MANIFESTATIONS IN CHILDREN WITH CONGENITAL HEPATIC FIBROSISRawat, P. / Kelly, D. A. / Sharif, K. / Lloyd, C. / Mckiernan, P. J. et al. | 2011
- S359
-
904 3-HYDROXY-C27-STEROID DEHYDROGENASE DEFICIENCY IN TWO CHINESE INFANTS AND SUCCESSFUL MANAGEMENT WITH HIGH-DOSE UDCAWang, J. S. / Fang, L. J. et al. | 2011
- S364
-
913 THE EFFECT OF THE PROMETHEUS® LIVERASSIST DEVICE ON CEREBRAL AMINO ACID METABOLISM IN ACUTE LIVER FAILUREBjerring, P. N. / Larsen, F. S. et al. | 2011
- S366
-
917 INHIBITION OF MONOCYTE SUBSETS DIFFERENTIATION WAS A NOVEL MARKER OF IMMUNOSUPPRESSION AND AN OUTCOME PREDICTOR FOR HBV ACUTE LIVER FAILURE PATIENTSGong, Y. / Wang, J. / Shen, L. / Zhang, Z. / Hui, Z. / Zhou, Y. / Zhang, P. / Zeng, H. / Li, H. et al. | 2011
- S367
-
919 MONITORING OXIDATIVE STRESS IN ACUTE-ON-CHRONIC LIVER FAILURE BY ADVANCED OXIDATION PROTEIN PRODUCTSLiu, H. / Han, T. / Tian, J. / Zhu, Y. Z. / Liu, Y. / Li, Y. / Xiao, X. S. / Feng, Y. Y. et al. | 2011
- S368
-
922 IMMOBILISING LACTATE OXIDASE TO REDUCE BIOREACTOR LACTATE CONCENTRATIONS, FACILITATING THE GROWTH OF ENCAPSULATED HEPG2 CELLS FOR USE WITHIN A BIOARTIFICIAL LIVER SUPPORT DEVICELintern, K. / Seiden, C. / Waugh, M. / Hodgson, H. et al. | 2011
- S369
-
924 CLASSIFICATION OF ACUTE LIVER FAILURE OF INDETERMINATE ETIOLOGY: USEFULNESS OF CLUSTERING ANALYSIS USING A SELF-ORGANIZING MAP (SOM)Nakayama, N. / Oketani, M. / Kawamura, Y. / Inao, M. / Nagoshi, S. / Fujiwara, K. / Tsubouchi, H. / Mochida, S. et al. | 2011
- S370
-
927 HEMOADSORPTION OF HIGH-MOBILITY GROUP BOX 1 IN SWINE ACUTE LIVER FAILURE MODELNishiyama, R. / Shinoda, M. / Tanabe, M. / Oshima, G. / Takano, K. / Fuchimoto, Y. / Miyasho, T. / Yamada, S. / Suda, K. / Fukunaga, K. et al. | 2011
- S371
-
929 GENE TRANSFER OF THE HIGH MOBILITY GROUP BOX 1 INHIBITOR IN RAT ACUTE LIVER FAILURE MODELShinoda, M. / Tanabe, M. / Takayanagi, A. / Nishiyama, R. / Oshima, G. / Sanuki, N. / Nagarekawa, T. / Takano, K. / Miyasho, T. / Yamada, S. et al. | 2011
- S372
-
932 ELEVATED CIRCULATING TH17 CELLS MAY INDICATE UNFAVORABLE PROGNOSIS IN PATIENTS WITH HBV RELATED ACUTE-ON-CHRONIC LIVER FAILUREZhang, G. L. / Xie, D. Y. / Lin, B. L. / Peng, L. / Xie, C. / Zhang, S. Q. / Zhang, Y. F. / Lai, Q. / Zhu, J. Y. / Zhang, Y. et al. | 2011
- S373
-
934 LONG-TERM FOLLOW-UP OF HEMODYNAMIC RESPONDERS TO PHARMACOLOGICAL THERAPY AFTER VARICEAL BLEEDING: A COHORT-STUDYAugustin, S. / Gonzalez, A. / Esteban, R. / Guardia, J. / Genesca, J. et al. | 2011
- S374
-
936 PORTAL VEIN THROMBOSIS AFFECTS PROGNOSIS OF CIRRHOTIC PATIENTS WITH PREVIOUS VARICEAL HAEMORRHAGEAmitrano, L. / Guardascione, M. A. / Menchise, A. / Martirio, R. / Scaglione, M. / Balzano, A. et al. | 2011
- S375
-
939 CORRELATION OF TRANSIENT ELASTOGRAPHY (TE) WITH HEPATIC VENOUS PRESSURE GRADIENT (HVPG): A PROSPECTIVE STUDYKumar, A. / Sharma, P. / Kumar, M. / Garg, H. / Sarin, S. K. et al. | 2011
- S376
-
942 LONG-TERM SURVIVAL AFTER VARICEAL BLEEDING: INFLUENCE OF EARLY EVENTS AND EVENTUAL RETURN TO THE COMPENSATED STAGE OF CIRRHOSISPoca, M. / Puente, A. / Graupera, I. / Hernandez-Gea, V. / Colomo, A. / Llao, J. / Concepcion, M. / Minana, J. / Aracil, C. / Guarner, C. et al. | 2011
- S377
-
944 PATIENTS WITH CIRRHOSIS WHO FAILED PRIMARY PROPHYLAXIS WITH NON-SELECTIVE BETA-BLOCKERS HAVE AN INCREASED RISK OF REBLEEDING DESPITE ADDING ENDOSCOPIC VARICEAL LIGATIONSouza, A. R. / La Mura, V. / Reverter, E. / Seijo, S. / Berzigotti, A. / Garcia-Pagan, J. C. / Abraldes, J. G. / Bosch, J. et al. | 2011
- S378
-
947 A NOVEL PROGNOSTIC INDEX IN CIRRHOTIC PATIENTS WITH HEPATORENAL SYNDROME TYPE-1Cazzaniga, M. / Dibenedetto, C. / Monti, V. / Accordino, S. / Gobbo, G. / Salerno, F. et al. | 2011
- S381
-
954 DETECTION OF HEPATOCELLULAR CARCINOMA BY GD-EOB-DTPA ENHANCED MRI: COMPARISON WITH CT DURING ARTERIAL PORTOGRAPHY AND HEPATIC ANGIOGRAPHYArai, K. / Yamashita, T. / Mizukoshi, E. / Sakai, A. / Kaneko, S. et al. | 2011
- S382
-
957 THE CLINICAL SIGNIFICANCE OF PLASMA OSTEOPONTIN LEVEL IN EGYPTIAN PATIENTS WITH HEPATITIS C VIRUS-RELATED HEPATOCELLULAR CARCINOMABessa, S. S. / Elwan, N. M. / Suliman, G. A. / El-Shourbagy, S. H. et al. | 2011
- S383
-
960 HEPATOCELLULAR CARCINOMA (HCC) IN HCV-RELATED CIRRHOSIS: A 20-YEARS SURVEY BY ITA.LI.CACazzagon, N. / Trevisani, F. / Giacomin, A. / Sergio, A. / Vanin, V. / Pozzan, C. / Del Poggio, P. / Rapaccini, G. / Di Nolfo, M. A. / Benvegnu, L. et al. | 2011
- S384
-
963 INTRADUCTAL ASPIRATION: A PROMISING NEW TISSUE SAMPLING TECHNIQUE FOR DIAGNOSIS OF SUSPECTED MALIGNANT PANCREATOBILIARY STRICTURESCurcio, G. / Traina, M. / Mocciaro, F. / Gentile, R. / Liotta, R. / Tarantino, I. / Barresi, L. / Gridelli, B. et al. | 2011
- S386
-
968 IMPACT OF GADOXETIC ACID (GD-EOB-DTPA)-ENHANCED MAGNETIC RESONANCE ON THE NON-INVASIVE DIAGNOSIS OF SMALL HEPATOCELLULAR CARCINOMAGranito, A. / Galassi, M. / Piscaglia, F. / Borghi, A. / Lucidi, V. / Golfleri, R. / Bolondi, L. et al. | 2011
- S387
-
971 ROLE OF IL-17, IL-6, AND IL-2 IN CIRRHOTIC AND NON-CIRRHOTIC PATIENTS WITH HEPATITIS B VIRUS-ASSOCIATED HEPATOCELLLULAR CARCINOMAWang, Q. / Fiel, M. I. / Parikh, K. R. / Manizate, F. / Luan, W. / Labow, D. M. / Hiotis, S. P. et al. | 2011
- S389
-
976 ER AGGREGATED HBV S PROMOTER DELETION WERE HCC TUMOR SPECIFICJiang, S. / Zheng, J. / Zhang, T. / Chen, X. / Lu, F. / Zhuang, H. et al. | 2011
- S390
-
979 OVEREXPRESSION OF THE RECEPTOR TYROSINE KINASE EPHA4 IN ADJACENT NONNEOPLASTIC LIVER IS ASSOCIATED WITH POOR PROGNOSIS OF HEPATOCELLULAR CARCINOMA PATIENTSJung, H. Y. / Jin, J. / Kim, S. H. / Lee, K. / Jang, J. J. et al. | 2011
- S391
-
982 ANTI-HBC AS A RISK FACTOR FOR THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH ALCOHOLIC CIRRHOSIS: A CROSS-SECTIONAL CASE-CONTROL STUDYKwon, P. S. / Jung, Y. K. / Soo Kim, Y. / Kim, J. H. / Kim, S. G. / Seok Kim, Y. / Lee, J. I. / Lee, J. W. et al. | 2011
- S392
-
985 COMBINATION OF SERUM BIOCHEMICAL MARKERS FOR EARLY DIAGNOSIS OF HEPATITIS B VIRUS-ASSOCIATED HEPATOCELLULAR CARCINOMA: ONE STEP BEYOND ALPHA-FETOPROTEINLin, Y. J. / Lee, M. H. / Yang, H. I. / Jen, C. L. / You, S. L. / Wang, L. Y. / Lu, S. N. / Chen, C. J. et al. | 2011
- S393
-
988 EVALUATION OF LOCAL RECURRENCE AFTER TREATMENT FOR HEPATOCELLULAR CARCINOMA BY CONTRAST-ENHANCED ULTRASONOGRAPHY: COMPARISON WITH DYNAMIC COMPUTED TOMOGRAPHY AND/OR MAGNETIC RESONANCE IMAGINGMartin-Algibez, A. / Fernandez-Vazquez, I. / Lopez-Martinez, C. / Gallego-Gallego, M. S. / San Roman, R. / Mufioz-Codocero, C. / Castellano-Tortajada, G. et al. | 2011
- S394
-
991 NATURAL ANTISENSE TRANSCRIPTS ANALYSIS IS EFFECTIVE FOR DIAGNOSIS AND CARCINOGENESIS OF HEPATOCELLULAR CARCINOMANagai, K. / Pak, S. / Kohno, K. / Chiba, M. / Murata, S. / Yasue, H. / Ohkohchi, N. et al. | 2011
- S396
-
996 ASSESSMENT OF LIVER FUNCTION BY METHACETIN C13 BREATH TEST PRE- AND POST LIVER RESECTION IN HCC PATIENTS IN MONGOLIANemekhbaatar, L. / Batmunkh, S. / Jazag, A. / Jigjidsuren, C. / Urtnasan, M. / Tseveg, T. et al. | 2011
- S397
-
999 THE PROGNOSTIC ROLES OF PREOPERATIVE AFP AND PIVKA-II IN PATIENTS WITH HEPATOCELLULAR CARCINOMA UNDERGOING HEPATECTOMY (CURATIVE RESECTION)Park, J. Y. / Lee, M. H. / Choi, G. H. / Kim, D. Y. / Ahn, S. H. / Kim, K. S. / Choi, J. S. / Han, K. H. / Chon, C. Y. et al. | 2011
- S398
-
1001 RAPID, MARKED WASH OUT AT CONTRAST ENHANCED ULTRASOUND IN NODULES IN CIRRHOSIS SHOULD RAISE THE SUSPICION OF CHOLANGIOCARCINOMAGalassi, M. / Piscaglia, F. / Lucidi, V. / Renzulli, M. / Cescon, M. / Venerandi, L. / Corbelli, J. / Vasuri, F. / Golfieri, R. / Bolondi, L. et al. | 2011
- S399
-
1003 THE EVOLVING CLINICAL SCENARIO OF HEPATOCELLULAR CARCINOMA OVER THE LAST 20 YEARS IN ITALYSanti, V. / Buccione, D. / Fatti, G. / Di Micoli, A. / Frigerio, M. / Grignaschi, A. / Farinati, F. / Del Poggio, P. / Rapaccini, G. / Di Nolfo, M. A. et al. | 2011
- S401
-
1009 VALUE OF B-MODE AND CONTRAST ENHANCED ULTRASOUND GUIDED CORE BIOPSY IN THE DIAGNOSIS OF MALIGNANT PORTAL VEIN THROMBOSIS IN LIVER CIRRHOSISSparchez, Z. A. / Radu, P. / Zaharia, T. / Diaconu, B. / Badea, R. et al. | 2011
- S403
-
1014 ALLELES AND GENOTYPES OF IL-18 AND IFN-GAMMA PROMOTER POLYMORPHISMS ARE ASSOCIATED WITH SEVERITY OF HEPATOCELLULAR CARCINOMA (HCC)Teixeira, A. / Mendes-Junior, C. / Fernandes, F. / Ferreira, S. / Mente, E. / Deghaide, N. / Sankarankutty, A. / Zucoloto, S. / Castro-e-Silva, O. / Donadi, E. et al. | 2011
- S404
-
1017 MAGNETIC RESONANCE IMAGING FINDINGS CORRELATE WITH PATHOLOGICAL SUBTYPE CLASSIFICATION OF HEPATOCELLULAR ADENOMASvan Aalten, S. M. / Thomeer, M. G. / Terkivatan, T. / Dwarkasing, R. S. / Verheij, J. / de Man, R. A. / IJzermans, J. N. et al. | 2011
- S406
-
1022 METABOLIC SYNDROME INCREASES THE RISK OF PRIMARY LIVER CANCER IN THE UNITED STATESWelzel, T. M. / Graubard, B. I. / Zeuzem, S. / El-Serag, H. B. / Davila, J. A. / McGlynn, K. A. et al. | 2011
- S407
-
1025 QUANTITATIVE HBV-DNA AND AST ARE STRONG PREDICTORS FOR SURVIVAL AFTER DETECTION OF HEPATOCELLULAR CARCINOMAWitjes, C. D. / Ijzermans, J. N. / van der Eijk, A. A. / Hansen, B. E. / Verhoef, C. / de Man, R. A. et al. | 2011